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GLOSSARY OF TERMS 
Childcare dependency grant: A social grant provided by the South African Social services 
agency to a family member responsible for the care of a disabled child. To qualify, the child 
should be severely disabled and require full time and special care. It applies to children aged 
between 0 to 18 years, living in households earning below 10,000 Rand per month. 
Children with special health care needs: Children who have or are at risk of a chronic 
physical, developmental, behavioural, or emotional condition and who also require health and 
related services of a type or amount beyond that required by children generally. 
Health service utilization: Quantification or description of the use of services by persons for 
the purpose of preventing and curing health problems, promoting, maintenance of health and 
well- being, or obtaining information about one’s health status and prognosis 
Health service satisfaction: Extent to which a patient is content with the health care they 
received from their service provider. 
Neurodevelopmental disorders: Heterogenous conditions characterised by developmental 
deficits in a variety of domains: social, cognition, motor, and language. 
Preschool child: Children aged between 2-8 years, before enrolment into the formal schooling 
system. 
Parent - professional partnerships: The relationships between parents and professionals 










HEALTH SERVICE UTILIZATION PATTERNS BY PRESCHOOL CHILDREN WITH AUTISM 
SPECTRUM DISORDER COMPARED TO THOSE WITH GLOBAL DEVELOPMENTAL 
DELAY AT A TERTIARY CENTRE IN SOUTH AFRICA 
Background 
Children with autism spectrum disorder (ASD) and those with global developmental delays 
(GDD) have complex health care needs that span long periods. Affected families in low 
resourced countries face substantial barriers in accessing care. Challenging behaviours in 
children with ASDs further complicates their service encounters and may result in forgone care, 
resulting in poor outcomes.  
Aim 
The aim of the study was to compare health service use (HSU) by preschool children with ASD 
and GDD attending developmental services at a tertiary hospital, and to explore the major factors 
impacting patterns of access. 
Methods 
 A retrospective cohort study was done, where 240 children with ASD and GDD (Non -ASD) 
were enrolled at a ratio of 1:1. HSU was determined by a retrospective review of their medical 
records, in the preceding 1 year. A structured questionnaire administered sought information on 
socio-demographics, child characteristics, perspectives, family distress level, experiences, and 
level of service satisfaction. Descriptive statistics and logistic regression analysis were used to 
evaluate primary study questions. Ethical approval was obtained by the University of Cape Town 
Human Research Ethics Committee (HREC: 397/2019). Families gave informed consent prior 
to enrolment. 
Results 
A total of 240 children were enrolled,116 had ASD and 124 had GDD. Their median age was 
5.2 years, and male: female ratio was 2:1. Higher co-occurring syndromic diagnoses were 
documented in GDD vs ASD at (46/124, 37.1% versus 14/116, 9.5%); (p<0.01) as well as higher 
comorbid diagnoses in GDD vs ASD at (51/124, 41.0% vs 14/116, 12.1%); (p=0.0001). A higher 
mean total health care visits was reported in those with GDD vs ASD (13.3 versus 11.5 (p=0.02), 
primarily due to higher specialist visits at 4.0 (2.0-5.5) vs 2.0 (2.0-3.0) (p<0.0001). Attendance 
for other services were similar in both groups, including therapy 6.0 (2.0-10.0), auxiliary services 
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0 (0-1.0), emergency visits 1.0 (1.0-2.0), and primary care visits 0 (0-1.0). Respiratory infections 
(91/240;37.9%) and unspecified fever (57/240; 23.8%) were the leading reasons for emergency 
visits in this cohort. Hospitalization was higher among children with GDD (38/124, 31%) than 
ASD (16/116, 14%), p=0.02. Factors associated with higher HSU included  primary diagnosis of 
GDD (p=0.02), female (vs male, average 1.59 more annual visits, p=0.04), being younger at first 
diagnosis (<2 vs ≥ 2 years, 1.72 more annual visits, p= 0.02), and having a concurrent syndromic 
diagnosis (vs none, 2.19 more annual visits, p=0.01). On logistic regression, controlling for these 
confounders, parental employment emerged as the strongest residual predictive factor for 
increased HSU (β 1.49, 95% CI -0.02 to 3.00, p=0.05).  
Conclusion  
Children with GDD had greater service use than those with ASD, primarily due to higher 
specialist visits for their higher syndromic and comorbid diagnoses. Core therapy services were 
underutilized despite being key interventions in both groups. Parental employment, an enabling 
factor, predicted greater service use. This calls for systemic reduction in access costs to optimize 






CHAPTER 1 INTRODUCTION AND LITERATURE REVIEW 
1.1 Background 
Autism Spectrum disorder (ASD) is a heterogenous condition characterized by persistent deficits 
in communication, social interactions and repetitive restricted patterns of behaviour that causes 
functional impairment (1). It greatly impacts on quality of life of the affected child, as well as that 
of their families. Signs of ASD usually develop in the first 2 years of life (2, 3), but most children 
are diagnosed from 3-4 years onwards. ASD has become a growing public health concern in 
recent years. In the United States of America (USA), documented prevalence in children 
increased from 1 in 150 in 2000 to 1 in 68 in 2017 (4-8).  A systematic review of prevalence data 
in 2012 reported a global ASD prevalence of 0.6%, but noted limited data from Africa (5). Global 
developmental delay (GDD) is a neurodevelopmental disorder (NDD) category, where the child 
demonstrates significant delays in at least 2 domains of functioning, and some may manifest 
intellectual disability (ID) later in life. Estimate prevalence data in low income countries is lacking, 
but burden has been rising globally. In the sub-Saharan Africa,  it was the leading NDD in 2014 
(6, 7).  
There is paucity of epidemiologic prevalence data of NDD in South Africa (SA). Despite the 
regularly held ‘National Household Surveys’ conducted by statistics SA, burden of disability in 
young children has never been captured at a population level. In one rural study done at 
Bushbuckridge, Northern Province, in 2002, they screened children aged 2 to 9 years for ID, and 
reported that 29.1/1000 had mild ID, while 6.4/1000 had severe ID (9). Another study done in 
rural SA in 2009 to determine the prevalence of NDD and behavioural problems in school 
children in grade R and 1 in Western Cape, authors reported that 21% had one or more possible 
developmental disability (10).  
Children with ASD have complex care needs that require a range of health care services. Though 
not curative, early identification and intensive interventions can ameliorate some impairments. 
Behavioural intervention therapy directed at core ASD symptoms has the strongest evidence of 
effectiveness in managing ASD (11-13). Early intervention therapies including speech and 
language therapy, occupational therapy, physical therapy and psychologic interventions have 
shown proven benefit (14, 15). However, these interventions take time to show improvement 
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and chronic management is required. Benefits of sensory integration therapy, and 
Complementary and Alternative medicine (CAM) approaches, and psycho-pharmacologic 
therapies remain controversial (16, 17). None the less, various studies have shown high use of 
psychotropics (18-21) and CAM therapies (22, 23) among children with ASD. A 2013 study in 
SA, observed high frequency of medication (24.6%) and CAM (40%) use in children with ASD 
(24). Children with GDD have similarly complex therapy needs spanning a long period.  
Concurrent co-morbid conditions are common among children with NDD which further 
complicate their care needs (25). Medical conditions seen in ASD include  gastrointestinal 
problems, seizures, sleep problems, allergies and recurrent infections which account for a large 
proportion of medical related visits (26-32). Co-occurring mental health problems reported 
include ID, anxiety, depression and attention deficit hyperactivity disorder (ADHD) (32-37). 
Behavioural problems in children with ASD frequently necessitate emergency care (26), and 
contribute to frequent health service usage (29, 35, 38). Co-morbidity patterns have varied  
across ethnic groups and geographic regions (27, 39). In a study done at a tertiary facility in SA 
in 2013 to characterize children with ASD, they reported a high prevalence of behavioural 
problems (89%), and most (72.4%) children in this cohort  were non-verbal (40). Similarly, 
comorbidities have been described in children with GDD (25), but they often show fewer 
behavioural challenges. Problem behaviours may be misunderstood by staff not familiar with 
these conditions. Furthermore, these families often require other support services to assist them 
go through their challenges, and they still require primary health care visits for growth and 
developmental monitoring and vaccinations.  
Studies in well-resourced countries have documented high service usage by children with NDD 
disorders compared to typically developing peers (41, 42). Children with ASD were reported 
have more challenges related to service usage, source of care, medical insurance and care 
coordination (43). Their hospital visits are costlier and these families are more likely to require 
government disability support than typically developing children (44, 45). Their care therefore 
poses a huge economic burden on insurance companies, society and to the government at large. 
The primary responsibility of accessing health services lies largely with families, who often report 
increased out of pocket costs in care, as well as reduced working hours and community 
participation. These factors contribute to higher stress levels, high frustration level, physical and 
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mental health issues in these families compared to those of typically developing  children (46-
48).   
These complexities raise the likelihood of unmet needs. Studies done in the USA have 
demonstrated substantially higher rates of unmet health needs in children with ASD compared 
to non-ASD children (49-51), and compared to children with other special health needs (CWSN) 
(52). Unmet needs reported included specialty services (49, 53), and therapy needs (53). The  
unmet needs increased as number of needed services increased, and especially in those with 
more severer limitations (51). There are limited services available in low resourced countries, 
hence greater care gaps are expected.  In a study done in SA in 2009 to analyse unmet needs 
of disabled children, only 26% were receiving rehabilitative therapy and these were largely those 
with motor deficits (54). A study assessing services available for children with disability in 
Western Health Sub-district of Cape Town in 2014 reported that there were limited disability 
services, with few trained providers for the population needs and inadequate special education 
facilities (55).  
Health service utilization (HSU) is a behavioural model that results from interrelationship of 3 
variables; predisposing, enabling and need factors (56).  From studies done in high income 
countries, need variables identified included disease severity, and comorbid conditions (51, 57, 
58), predisposing factors included social-demographic and cultural factors (59, 60) while 
enabling factors included family income and possession of medical insurance (52). Health 
system factors also affect HSU. Among systemic factors reported in studies have included unmet 
expectations (38, 61, 62), limited knowledge by providers (53, 63), difficulties in navigating 
complex health systems (61, 64), and poor provider-carer communications (64, 65). The rising 
burden of these disorders are likely to impact on the provision and organization of services and 
costs of care (42, 44). Furthermore, poor service organization, inefficient systems, and 
bureaucratic systems are common system barriers. 
There is a dearth of information on determinants of HSU by children with NDDs in resource 
limited countries. In the SA context, despite the rising recognition of these disorders in the 
community, the services available remain limited. Majority of affected households attend 
services in the public health system, where the initial evaluations and formulation of the 
management plan is done at a tertiary centre, then subsequently, core therapy and auxiliary 
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services are accessed at community day hospitals (CDH), which are primary level facilities. Only 
a minority of cases attend care in the private sector, largely due to the cost restrictions. The 
rising service demand is likely to broaden the existing unmet needs, and increase disparities in 
access (54). There is currently limited information on how affected families juggle around these 
complexities to access care. This retrospective study reviewed HSU patterns of children with 
ASD and GDD accessing services at the Red Cross War Memorial Children’s Hospital (RXH). 
We compared HSU between these two groups, and explored potential factors impacting on 
service usage. Findings will inform policy makers on appropriate structural organization for 
planning of future service delivery and resource allocation for more efficient services.  
1.2  Rationale of study 
 In 2009, the estimated prevalence of NDD and behavioural problems among early school-age 
children in Western Cape was reported at about 21%, with ASD and GDD as the leading 
causes(10). Both children with ASD and GDD have complex service needs, covering core 
therapies, treatment for comorbid conditions, and other support services. These often require 
recurrent service use that spans long periods. These demand significant time investment and 
translates to substantial health care costs for affected families. Many households in low income 
countries have limited health financing, and even where services are state paid, overhead costs 
(such as transport), incurred by families pose significant barriers to care. Challenging behaviours 
are common among children with ASD, and often pose further challenges in their health 
encounters. Households with children with ASD therefore face more access barriers, compared 
to those with other NDD. Mostly, families are responsible for ensuring children attend services 
needed. However, when families feel overwhelmed, it may delay diagnosis, and lead to different 
care-seeking approaches, fragmented access, or discontinued care. Suboptimal care may result 
in poor outcomes, with lifelong dependency and disability lost years. Currently, all children with 
NDD receive similar health services. It remains unclear whether there is any meaningful 
difference in patterns of service use between households with children with ASD compared to 
those with GDD. This study sought to shed light on how these groups navigate their complex 
care needs. This will inform any additional supports needed to optimize access to care for these 
groups. There is scarcity of published studies in this area in SA, which underscores the 
importance of this study. This information is important for policy makers and health planners in 
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planning for future health service delivery and refining pathways to care of these children and 
their caregivers.    
1.3 Study goal 
The goal of the study was to describe HSU patterns of pre-school children with primary diagnosis 
of ASD attending services at the RXH and compare with those with GDD (non- ASD), and to 
evaluate factors that influence these usage patterns. 
1.4 Study Objectives 
1. To compare frequency of HSU utilization of children with ASD and that of children with 
GDD at RXH. 
2. To compare unmet health care needs for children with ASD and those of children with 
GDD at RXH. 
3. To compare level of health service satisfaction by carers of children with ASD and those 
with GDD 
4. To evaluate how socio-demographics, CAM use and family stress levels influence HSU 
patterns among children with ASD and those with GDD. 
1.5 Hypotheses 
Hypothesis 1 (Objective 1) 
H0:  There is no meaningful difference in the frequency of HSU in children with ASD and those 
with GDD.  
Ha:  Children with ASD have higher HSU than those with GDD 
Hypothesis 2 (Objective 2) 
H0:   There is no difference in unmet health care needs for children with ASD and those with 
GDD  
Ha:  Children with ASD have higher unmet health service needs than those with GDD 
 Hypothesis 3 (Objective 3) 
H0:  There is no difference in level of satisfaction with health services in children with ASD and 
those with GDD  
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Ha:  Children with ASD have higher level of satisfaction with health services than those with GDD 
Hypothesis 4 (Objective 4) 
H0: Families from low socioeconomic backgrounds (SEB) are more likely to have lower HSU 
than those from high SEB. 
Hypothesis 5 (Objective 4) 
H0:  Use of CAM by families is more likely to negatively affect HSU than those not using CAM.  
Hypothesis 6 (Objective 4) 
H0:  Families with high stress levels have higher HSU than those with less family stress levels.  
1.6 Theoretical model 
A modified version of Andersen’s Behavioural Model of Health service (56) was used as the 
study frame work. This model proposes that health service use is a health behaviour that results 
from interaction of diverse variables that can be grouped into 3 categories; predisposing factors 
(static factors that describe the likelihood of an individual to seek care in a given situation), 
enabling factors (environment and resources available), and need variables (event or medical/ 
psychological conditions that might facilitate a greater need for services). Variables that were 
considered in these categories were as follows: 
1. Predisposing factors:  age, gender, race, family size, caregiver’s marital status, education 
level, social supports, perspectives, previous health service experiences, level of satisfaction, 
use of medications and CAM therapies.  
2. Enabling factors: Caregiver employment, family income, health financing, travel costs to the 
hospital, time taken to come to health facility, residence neighbourhood. 
3. Need variables: Functional level or severity of illness, comorbid syndromic diagnosis, chronic 








1.7 LITERATURE REVIEW 
1.7.1 Introduction 
This section examines existing literature on the subject under the following subheadings: health 
care needs of the children, effects of comorbidities on HSU, unmet needs in service use, HSU 
patterns among children with NDD, factors influencing HSU: sociodemographic factors, 
perspectives, stigma and preferences, family stress level and health system factors affecting 
service use, and provides a summary of gaps in existing knowledge.  
1.7.2 Health care needs of children with ASD and GDD 
Core symptoms of ASD include deficits in social skills and communication and repetitive 
restricted behaviours, attitudes, and interests. Intensive behavioural therapies have been shown 
to improve socialization and behavioural functioning (11-13). Early intervention therapy (EIT) 
covering occupational therapy,  speech therapy, and physiotherapy  have also shown significant 
benefit for better outcomes (14, 15). Educational and pharmacologic interventions targeting 
specific symptoms may be used in older children. However, none of these therapies are curative. 
Services rendered often vary depending on the local resources. Clinical practice guidelines for 
ASD in the USA recommend provision of intensive intervention, with active management of the 
child at least 25 hours per week, 12 months per year (66, 67). Sustained and chronic 
management is required as interventions take time to show benefit (68). Children with ASD  
require more EIT, educational and behavioural services than children with other special needs 
(69, 70). Moreover, families may additionally require support services such as mental health 
care and family counselling. In many well-resourced countries, home health care services are 
available. However, in most resource-limited countries, a less rigorous approach is adopted, 
where the intensity and duration of therapy is unspecified.  
Children with ASD suffer various comorbid medical conditions including gastrointestinal 
problems, seizures, sleep problems, allergies and recurrent infections, which account for a large 
proportion of medical related visits in this population (26-32). Most (87-97%), express diverse 
psychiatric comorbidities including; ID, ADHD, anxiety, behavioural and conduct problems and 
depression  (29, 31, 35, 37). ADHD rates have ranged from 20-80% (29, 30, 32), while co-
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occurrence of ID has been reported in 50-80% (29, 36). Among teenagers with ASD, 
schizophrenia was reported in approximately 30% (71). In general, children with ASD express 
more challenging behaviours and emotional disturbances than children with other NDD (26, 35, 
72). Gurney and colleagues (2006), analysing data from the National Survey of Children’s 
Health, found that children with ASD had significantly higher prevalence of depression and 
anxiety (38.9% vs 4.9%), and behavioural or conduct problems (58.9% vs 5.2%) than children 
without ASD. They also reported that respiratory, food and skin allergies occurred more 
commonly in the ASD group, than other CWSN (25, 63). In another study by Horovitz and 
colleagues (2011), they observed that behaviour patterns varied between diverse ethnic groups 
in up to 5 of 10 domains tested (73). Mayes and colleagues (2011), examining predictor variables 
of ASD symptoms observed that behaviour and mood problems were significantly more common 
in children from lower socioeconomic backgrounds, controlling for gender and race. These 
groups also had more severer ASD symptomatology (74). Furthermore, Mandell and colleagues 
(2005), observed that African- American children and minority groups were more likely to exhibit 
aggressive behaviours than their white counterparts, but there were no differences observed in 
stereotypic and self-injurious behaviour (75). 
Similar findings have been observed in low-resourced countries. Mpaka and colleagues (2016), 
looking at children attending neurodevelopmental outpatient clinics in the Congo reported high 
(93.2%) rates of comorbidity in children with ASD, but the significant comorbidity was with          
epilepsy (72.5%) and ID (75.8%), compared to children with other NDD (p>0.001). ADHD was 
reported in 14.5% and schizophrenia in 11%. The number of comorbidities per child ranged from 
1-4, with more comorbidities reported in older children (39). Similarly, in a study by Springler and 
colleagues (2013) done in Western cape province in South Africa that examined children with 
pervasive developmental disorder, they a found high prevalence of behavioural problems (89%) 
and 72.4% were non-verbal (40). Belhadj and colleagues (2006) looking at a Tunisian population 
of children with ASD, reported comorbid ID in over 60% of cases studied, and 51.2% were non-
verbal (76). 
1.7.3 Effect of comorbidities and health service usage  
Various studies have examined the effect of comorbidities on presentation and HSU. Problem 
behaviours in ASD may mask underlying medical conditions and delay diagnosis (77, 78).        
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Antshell and colleagues (2011), observed that comorbid psychiatric conditions were associated 
with latter ASD diagnosis and reduced symptom improvement (79). Comorbidities have also 
been associated with poorer prognosis (32). Most recommendations suggest that health care 
providers should pay attention and screen for comorbidities before starting any treatment for 
ASD (80).   
Comorbidities often contribute to need for specialist and emergency visits. In a study done in the 
USA by Ahmedani and colleagues (2012), to characterize comorbid psychiatric conditions in 
children with ASD, they reported that 66.4% had a comorbid psychiatric condition. These tended 
to be those older, they suffered poorer outcomes, and were more vulnerable to recurrent service 
use than those without. This group was also more likely to be dissatisfied with services (38). 
Aggression has been shown to be one of the predictors of psychiatric hospitalization of children 
with ASD (81, 82). Children with more severer illness tend to have higher HSU (58, 83). Similar 
findings were observed by Zablotsky and colleagues (2015) in the USA, who reported that 
children with ASD and ID, especially those with co-morbid psychiatric conditions represented 
the most vulnerable population with recurrent service use and medication usage (84). 
Elsewhere, a Danish study comparing patterns of hospital contact of children by ASD versus 
non–ASD over a 10-year period, found that children with ASD had higher contact for diverse 
medical conditions than non-ASD children, both in periods before and after ASD diagnosis. They 
however, cautioned against using hospital data sources to correlate ASD with specific somatic 
diseases as this may be misleading given diverse criteria for entry to hospital care (85). From 
these studies, it appears that comorbid physical and mental conditions increase likelihood of 
service use in high income countries, but their impact has not been assessed in low income 
countries. 
1.7.4 Unmet health service needs in NDD 
From studies done in the USA, unmet needs in children with NDD have varied with type of 
services and child characteristics. Krauss and colleagues (2003) found that over one third of 
children with ASD reported experiencing problems accessing specialty care service, compared 
to just one fifth of children with ID and one fifth of children with other special care needs (49).  
Further, Chiri and colleagues (2012), assessed unmet needs and problems accessing core 
services (preventive, specialty care, therapy, and mental health) by children with ASD. They 
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found that for this group, unmet needs ranged from 2.5% for preventive services, and up to 25% 
for mental health services. More unmet therapy and specialist needs were observed in children 
with ASD, than in those with other special health needs (CWSN) for all services (53). Benevide 
and colleagues (2016) examined population-based trend in unmet need for therapy service in 
children with ASD and CWSN and found ASD children to have 1.4 times higher risk of unmet 
needs (50). Similarly, Vohra and colleagues (2013) compared access to services, quality of care 
and family impact among children with ASD versus those with other NDD. They reported that 
children with ASD, were significantly more likely to report difficulty using services, lack of sources 
of care, inadequate insurance cover, lack of shared decision-making and care coordination and 
adverse family impact compared to children with NDD or ID alone (43). Warfield and colleagues 
(2006) in the USA examined service use by CWSN and reported that as the number of needed 
services increased, so did the number of unmet needs. This increased to 25% for children 
requiring 5 or more services. The authors also noted that mental health and home health 
services were the leading unmet needs (51). Common predictors for unmet needs for CWSN 
was low incomes and lack of insurance (62, 86). Other studies looking at all CWSN, reported 
that those with severer limitation of activities tended to have greater unmet needs than those 
with fewer limitations, and that they were also more likely to have delayed or forgone care entirely 
(51, 87). 
Many low-resourced countries have limited services available for children with NDD. In SA, 
Grover and colleagues (1987) described services available for children with ID in Cape Town 
and demonstrated significant disparities between ethnic groups, and a serious under provision 
of services for the black African population (88). Subsequently, Redfern (2014) assessed 
disability prevalence in children accessing various services in Western Health Sub-district of 
Cape Town and sought to establish services available them. He reported that there were limited 
disability services, with few trained providers for the population needs and inadequate special 
education facilities (55). In study done by Saloogee and colleagues (2009) to analyse unmet 
needs of disabled children in peri-urban township setting in Gauteng, they reported that only 
26% were receiving rehabilitative therapy. Those with motor impairments were more likely to 
receive therapy compared to those with intellectual impairment (44% vs. 8%, p<0.0001). In this 
study, only 26% of those that required assistive devices were receiving them (54). None of these 
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studies looked at the ASD group specifically, yet they appear to be a particularly vulnerable 
group, given the above stated literature. 
1.7.5 Patterns of health services utilization by children with NDD 
Available literature on HSU by children with ASD originates largely from high-resourced 
countries (43, 60, 84, 89-94). Most analyses have focused on administrative database records, 
which may not capture family centred variables. These studies have focused on outpatient visits, 
emergency department visits and hospitalizations. 
1.7.5.1. Outpatient health service use patterns 
Gurney and colleagues (2006) undertook a large cross sectional survey of data from the National 
Survey of Children’s Health 2003-2004, over a 12 month period, which revealed that children 
with ASD had a significantly (p<0.001) higher mean number of physicians visits for preventive 
care, non-emergency care, and emergency department (ED) visits than typically developing 
children (63). Liptack and colleagues (2006) also examined data from USA national samples  
and compared children with ASD and those without ASD, and found that children with ASD had 
greater utilization of services in terms of annual outpatient visits (41.5 vs 3.3), annual physician 
visits (8.0 vs 2.2) and number of medications prescribed annually (21.8 vs 2.1) (42). Similarly, 
when comparing health service utilization of children with and without ASD in the same health 
care plan, Croen and colleagues (2006) found that children with ASD had substantially higher 
annual mean number of total clinic (5.6 vs 2.8), paediatric (2.3 vs 1.6) and psychiatric (2.2 vs 
0.3) outpatient visits  compared to those without ASD (44). These findings were further echoed 
in surveys using the North Dakota Medicaid health claims from 1998 -2004 (95).  
A study by Akins and colleagues (2014), compared utilization of conventional treatments in pre-
schoolers with ASD and those with NDD. They reported that children with ASD received more 
hours of conventional services compared to those with other NDD (17.8 versus 11;p<0.001) 
(96). Cummings and colleagues (2016), looking at multiple health systems in the USA (2009 -
2010) found that children with ASD had greater health care use in many categories, but were 
less likely to receive important preventive services including influenza vaccination and other 
vaccinations compared to typically developing children (60). Nageserwan and colleagues 
(2011), analysing the 2005 National Survey of Children with special health care needs, reported 
that children with developmental disabilities had 2.3 odds of having difficulties using services, 
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compared to 2.6 in those with mental disorders compared to those with physical disability (97). 
In a systematic review by Tregnago and colleagues (2012)  to asses of disparities in health care 
of individuals with autism in the USA, they found that children with ASD utilize a greater number 
of health care services compared to children with other developmental disabilities, and had 
higher health costs (86). Kraus and colleagues (2003) examined access to specialist services 
by children with special care needs. They observed that over one third of children with ASD, 
compared to just one fifth of children with ID and one fifth of children with other special care 
needs reported experiencing problems accessing specialty medical care services (49).  
Similarly, hospitalization rates have been found higher among children with ASD children. In the 
USA, Birenbaum and colleagues (1990), reported that 10% versus 3% of children with ASD were 
hospitalised during a year period, compared to all children. Elsewhere, in a population- based 
study done by Arim and colleagues (2017) using administrative data to compare HSU in children 
with and without NDD in Canada, they reported that those with NDD had three times more 
hospitalizations and two times more physician visits than those without. They also had higher 
use of psychostimulants and specialists visits (41). The three leading diagnoses in those with 
NDD were neurotic disorders, personality disorders, and other non-psychotic mental disorders 
(7.9%), acute respiratory infections (3.5%), and general symptoms (3.3%). Peacock and 
colleagues (2012) compared effects of comorbid medical conditions on health expenditures in 
ASD vs typically developing children and reported that children with ASD were estimated to have 
more than 2 times higher annual hospitalization costs and six times higher annual medication 
expenses than typically developing children. Medication costs were largely due to psychotropic 
medications (45). From this available literature, it appears that in some studies in the first world 
context, children with ASD attend more visits, but on the other hand there appears to be some 
aspects of care which are relatively neglected, including important routine health care visits such 
as for vaccinations. Most of these publications are based on studies from high income countries, 
but there is a significant gap in the understanding of how these issues play out in low resource 
settings. 
1.7.5.2 Emergency department visit patterns 
USA based studies comparing emergency department (ED) visits in ASD versus non-ASD 
children have documented higher usage by children with ASD (26, 27, 98). Reasons 
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underpinning these emergencies have largely been routine childhood illnesses  and accidents 
or injuries (99, 100). McDermont and colleagues (2008) compared the type and frequency of 
injuries presenting to ED by ASD versus typically developing children. The relative rate for ED 
visit for injury was 1.2 after controlling for age and gender. Treatment for poisoning and for self-
inflicted injury were both 7.6 times as frequent children with ASD (99). Subsequently, Kalb and 
colleagues (2016) assessed causes of paediatric injuries presenting to ED and reported that the 
odds of an injury related visit was 54% greater among children with ASD than those with ID, but 
48% less in those without ASD or ID. Main causes of ED visits among children with ASD was 
self-inflicted injuries or poisoning (100). Innauzzi and colleagues (2014) reviewed the 2010 
National Emergency Database to identify medical problems presenting to ED by children with 
ASD by age group. They observed that psychiatric presentation was highest in the younger ages 
(12-15 years), while epilepsy was the highest presenting problem in those above 16 years (26). 
Similar observations were made by Kalb and colleagues (2012), who found that children with 
ASD were nine times more likely to present to the ED with a psychiatric crisis compared to those 
without ASD. Externalizing symptoms such as severe behaviours, including aggression and self-
injurious behaviours were the leading causes of ED visits (34). Weiss and colleagues (2018) 
reported that immigrants had higher risk of psychiatric ED use, probably because of lack of 
awareness of mental health services and resources to effectively find accessible community 
support services for their child (101). Deavenport and colleagues (2015) assessed factors 
associated with ED utilization and urgency of visits, using data from various hospitals in the USA. 
The top reasons for ED visits by children with ASD was upper respiratory infections, and they 
had 0.26 times more annual ED visits, and were 2.6 times (p<0.001) more likely to have non-
urgent visits (p<0.001), and their visits were less likely to result in hospitalizations compared to 
non-ASD children (p<0.001)(102). This available data clearly suggests increased ED use by 
ASD children than those non- ASD in well-resourced countries, but there is paucity of data on 
patterns of ED visits in children with NDD from low income countries.  
1.7.6 Factors that influence health service use  
1.7.6.1 Sociodemographic factors and service use 
Various USA based studies have analysed the social determinants of HSU among children with 
ASD. Socially disadvantaged communities had lower access and uptake of services (59, 103), 
and their diagnosis occurred much latter (104). Thomas and colleagues (2007) looking at access 
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to autism-related services by families, reported that access to care was limited for ethnic and 
minority families with low parental education (104). Liptack and colleagues (2008) reported that 
they utilized fewer of early intervention ASD specific services  and had more difficulty accessing 
services (65). Irvin and colleagues (2012) found that those in higher socioeconomic status (SES) 
were associated with receiving more types of services such as “Applied behaviour analysis 
(ABA) - based services, and occupational therapy, than those from lower SES (105). Zukerman 
and colleagues (2016) observed that poor families were less likely to believe that they could 
change their child’s condition. Parents of minority were more likely to believe that the condition 
was temporary, compared to white parents. Those with less education and of lower SES were 
more likely to think that their child’s condition was a mystery (106).  
Kogan and colleagues (2005) examined the impact of underinsurance on health care access 
among CWSN. They observed that underinsured children were disproportionately represented 
in low income families and were significantly more likely than fully insured children to have unmet 
health needs and difficulty in obtaining specialty referrals (52). In a systemic review of disparities 
in health care access among families with children with ASD by Tregnago and colleagues (2012), 
they reported that high costs of care and lack of medical insurance were shown to limit access 
(86). In study by Chiri and colleagues (2012)  examining unmet needs and problems accessing 
core services among children with ASD, they noted that lack of health insurance was a barrier 
to access  (53). In Nyugen and colleagues (2016) reported that having public insurance was 
associated with having <15hrs/week of individual services while mother having a bachelor’s 
degree was associated with having <15hrs /week of classroom-based services (59). Similar 
findings were reported in study  to asses role of parental education on service delivery and 
outcomes in children with ASD, where high level of parental education was associated with 
greater service adequacy and number of services received (107). Durkin and colleagues (2015), 
explored barriers to screening and diagnosis of ASD in low income settings and observed that 
there exists significant disparities in autism research, and children from  low socioeconomic 
backgrounds were less likely to be diagnosed (108).  
Age of child has been correlated with service use. Cidav and colleagues (2013), examined 
differences by age in service use and expenditures and reported that younger age groups  
utilized more of community-based services unlike older children who were reported as using 
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more restrictive, institution- based care (103). While examining age-related trends in treatment 
use among children with ASD, Mire and colleagues (2015) observed higher early intervention 
service usage among the younger children. Most access to care for treatments peaked in the 
preschool years and visit frequency decreased with age, except access to care for the use of 
psychotropic medications (83). One study also noted  a general decline in utilization of health 
services in youth with ASD as they transition to adult care with the exception of ED visits (109). 
Ethnic differences have been observed in early identification of ASD in USA based studies. 
Mandel and colleagues (2005), observed that different cultures respond differently to similar 
impairments of ASD, including interpretation of symptoms, family decisions regarding 
interventions, and interactions between families and the health care system (75).  Ancestral 
status and ethnicity have also been shown to predict use of specialized diagnostic procedures 
required by children with ASD (92). Examining impact of ASD on the family unit, Kogan and 
colleagues (2008) reported that compared to white children, non-Hispanic black children were 
more likely to report delayed or forgone care, have no usual source of care, no personal 
physician or nurse, have difficulty receiving care, or lack at least one component of family- 
centred care (62). Culture and race have been shown to influence psychiatric comorbid 
diagnoses among children with ASD (110, 111). On the contrary, the study by Nguyen and 
colleagues (2016) evaluating sociodemographic disparities in service use by children with ASD, 
observed that black American children entered the intervention earlier, compared to white 
children (2 vs 2,6 years, p=0.001), but observed decreased access to mental health services by 
non-white children (59). Ahmedani and colleagues (2012) looking at service access for children 
with ASD and psychiatric comorbidity did not also find race to be significant predictor of service 
access (38).  Magana and colleagues (2012), reported greater disparities in care for ethnically 
diverse children with ASD, compared to children with other disabilities (112). Generally, these 
studies from high income countries reported varied conclusions on the effect of ethnicity or 
ancestry on service use in children with NDD, and it is likely that other factors are likely to 
confound it.  
1.7.6.2 Family perspectives, experiences and stigma and service use 
‘The Health belief model’ (113) and the ‘Theory of planned behaviour’ (114) define and 
categorize which factors may lead to service use. The later focuses on how attitudes influence 
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social behaviours. Family decision making and choices around service utilization is a health 
behaviour. Understanding family perspectives in ASD care and subjective norms around care of 
ASD is an integral to understanding HSU. Cultural differences in health care seeking have been 
observed across different communities (115, 116). Parents’ perceptions of illness plays a crucial 
role in determining treatment decisions (106, 117, 118). Care priorities and preferences differ by 
families based on their perception of severity (117), as well as other contextual or competing 
pressures.  
Several mental disorders (119) and ASD (120) are frequently attributed to supernatural and 
traditional forces in Sub Saharan Africa and in Asia (121); these include lineage curses, enemies, 
an action of the devil and a punishment from God. To date, no single specific biologic or aetiology 
of ASD has been confirmed, though genetic variations are increasingly getting recognized as 
likely causes of the ASD behavioural phenotype. Caregivers may hold divergent beliefs and 
misconceptions about perceived causes and prognosis of developmental disorders in their 
children (121, 122). Parent perceptions on potential causes of NDDs (and ASD in particular) 
have evolved (106, 123, 124), as the scientific community hypothesizes about the 
pathophysiologic mechanisms underpinning ASD has changed in the last 50 years. However, 
there is less investigation on how these family perspectives affect ASD care. Al Abner and 
colleagues (2010) studied this link between parent causal perspectives and service use found 
that beliefs have a strong effect on treatment use. They found that theories about both external 
and hereditary causality were associated with use of nutrition supplements, especially special 
diets and nutrition supplements (117). In a systemic review by Carlon and colleagues (2013), 
they reported that many factors influence utilization of treatments, and suggested that future 
studies should asses relative weighing of these factors when making decisions (125). 
Zucherman and colleagues (2017) reported that higher parent-reported severity of illness was 
associated with higher likelihood of using therapy and attending specialist provider visits (58).  
In a study by Chadeiz and colleagues (2018), to correlate maternal belief on ASD aetiology and 
HSU, authors reported that belief in environmental causes was associated with receiving >20hr 
per week of ASD related therapy, whereas believe in environmental exposures, vaccines and 
medication as cause of ASD, was associated with preference for CAM use (118).  
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Families of children with ASD experience high stigma universally, covering high income 
countries (106, 126-128), especially among immigrant communities (129, 130), as well as low 
income nations (47, 122, 131). Families have reported experiencing either internal stigma 
(feelings of shame and the anticipation of prejudice that prevents people talking about their 
illness and looking for help), and enacted stigma (such as evasion and discrimination) (61).  A  
study by Divan and colleagues (2012) in India reported that families would be ashamed if a 
family member was diagnosed with ASD (132). Similar findings were reported in studies from 
Africa. Ambikile and colleagues (2012) in Tanzania, reported that caregivers of children with ID 
and ASD experienced social exclusion and discrimination (47). Tilahum and colleagues (2016),  
in Ethiopia reported high rates of stigma among  caregivers of ASD children; 43% worried about 
being treated differently, 45.1% felt ashamed about their child’s condition, and 26.1% made effort 
to keep the child’s condition secret. This did not depend on the child’s diagnosis, gender, of 
caregiver education level (all p>0.05). Reported stigma was significantly higher in those who 
sought traditional help (p>0.001), provided supernatural explanations for their child’s condition 
(p=0.03), and families who identified as being part of the orthodox Christian faith (p=0.02). The 
families also reported unmet needs in education provision (74.5%), health service provider 
(47.1%), financial support (30.4%) and developmental supports (27.5%) (122). This literature 
demonstrates that family perceptions of illness and stigma appear to determine their service use, 
but this did not been assessed locally. 
1.7.6.3 Family stress level and service use 
Families of children with NDD report increased out-of-pocket costs in care, reduced working 
hours and labour force and community participation (62). Families of children with ASD 
experience increased risk of stress, feeling of frustration and isolation and physical and mental 
health issues and decreased quality of life compared to those with other NDD (46, 48). Societal 
stigmatization, coupled with high care demands often lead to high stress levels (133). There are 
differences in treatment access and utilization with parent mental health in children with and 
without ASD (63, 134). The Tanzanian study by Ambikile and colleagues (2012), examined 
challenges of caring for children with mental disorders, and reported that psychologic and 
emotional challenges observed included being stressed by caring tasks, and having worries 
about the present and future lives of their children. They experienced sadness and inner pain or 




Parental mental health has been shown to impact on access to services for children with and 
without ASD (62, 63, 134). Individuals with ASD experience a high frequency of negative life 
events, trauma, and greater stress when compared to typically developing peers (135, 136). The 
stressors are in turn associated with decreased social functioning (135), and depression (137) 
which may lead to greater ED use. Thomas and colleagues (2007) looking at access to care for 
autism- related services reported higher rates of general service use rates among families with 
higher stress (104). Similar observations were made by Lunsky and colleagues (2012), in a 
prospective study in Canada, that that looked at predictors of ED visits in children with ASD, with 
and without ID. They reported that life events predicted ED visits in individuals with ID (138). 
Subsequently, Lunsky and colleagues (2017) also looked at predictors of ED use among 
adolescents with ASD observed that families who reported that their families were experiencing 
distress at baseline predicted higher ED attendance (139). This literature from high income 
countries indicates that among families with ASD, family stress level increases the likelihood of 
recurrent ED visits. There is need for better understanding of how this plays out in local settings. 
1.7.6.4 Medication, CAM use and service use 
The lack of specific standards of care for comorbidities in children with NDDs are subject to use 
of both conventional and CAM use  (84, 140-142). Higher CAM use has been observed in 
children with ASD, in 28-95% cases (143-145). Croen and colleagues (2006) reported that 
children with ASD were nine times more likely to use psychotherapeutic medications and twice 
as likely to use gastrointestinal agents than children without ASD (44). Similarly, a longitudinal 
study in Korea to asses psychotropic use in ASD children aged 3-17 years found 30% usage 
(18). There is little evidence to support efficacy of use of these treatments for core symptoms of 
ASD (140, 146). Controlled studies have found these therapies to be ineffective (16, 144). 
Hanson and colleagues(2007) summarized the many reasons given to explain why parents 
appear to employ CAM more regularly for ASD: lack of efficacy of conventional treatments, poor 
access to standard rehabilitation programs, lack of agreement as to what treatments are best, 
better comfort provided by CAM professionals, empowerment of families, preference for less 
invasive and more ‘natural’ remedies and dissatisfaction with complimentary care (144). Most 
families adopt multiple treatment approaches and may discontinue treatment if they do not see 
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perceived improvement (147). The lack of evidence on effectiveness, together with unclear 
biologic determinants of ASD leaves parents in dilemma (35, 141). Safety concerns exist for 
some of these therapies.  
CAM use has been shown to affect conventional therapy uptake in the USA. In a study by Levy 
and colleagues (2010), families experiencing long diagnostic delays were more likely to use 
CAM like supplements and delay onset of conventional care. CAM use was  higher when access 
to conventional care was limited (35). Zuckerman and colleagues (2017) reported higher CAM 
use in first time mothers who felt unsure of the aetiology of ASD, compared to mothers who cited 
specific reasons and in those with severer illness. They also observed higher CAM use in those 
with more severe illness (94). On the contrary, in the study by Akins and colleagues (2014), 
comparing utilization of conventional treatments and CAM in pre-schoolers with ASD and those 
with NDD, they found CAM use to be similar in both groups, with ASD at 39.6% versus 30% in 
NDD. Higher CAM was observed in those using the most intensive ASD-specific services, those 
with higher level of parental education and in those of non-Hispanic ethnicity (148). This literature 
therefore remains inconclusive on how CAM use impacts health service use. In SA, a study by 
Louw and colleagues (2013), reported high frequency of medication use (24.6%) and CAM use 
(40%) in children with ASD, but they did not explore how the use of CAM therapies affected 
service use. 
1.7.6.5 Health system factors and service use 
Caregivers of children with ASD have reported diverse challenges navigating health care 
services (61). These have ranged from long waiting times to evaluation, disinterest of clinician 
in parent’s core concerns and short consultation times (38). Some have reported poor 
communication and over-helming environments (64). Others report failure of health services to 
meet their expectations and dissatisfaction with services received (38, 61). Health workers may 
either encourage or disenfranchise individuals from engaging in treatment, especially those who 
require care across multiple areas. Lack of confidence in competency of providers have led to 
patients preferring to visit ED instead of primary providers (63, 149). Vohra and colleagues 
(2014), looking at the 2009-2010 National Survey of Children with Special Health Care needs in 
the USA observed that caregivers of children with ASD were more likely to report difficulty in 
using services, lack of source of care, lack of shared decision making and care coordination 
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compared to those with other developmental disabilities (150).  In a study by Chiri and colleagues 
(2012) comparing unmet needs and problems in accessing core services in children with ASD 
and those with other special needs, they reported that families with children with ASD were more 
likely to report provider lack of skills to treat the child as a barrier to obtaining therapy and mental 
health services. They concluded that organizational features of managed care programs and 
provider characteristics pose a barrier to accessing care (53).  
Parent -professional partnerships (PPP) can be  defined as relationships between parents and 
professionals that are based on respect, trust, and equality (151). Parents with high quality 
partnerships are more likely to be satisfied with their current services and less likely to express 
high level of unmet service needs (151, 152). Families were more likely to delay or omit services 
if they perceived a lack of communication and partnership with the providers (38, 153). Families 
of children with ASD reported experiencing less collaboration, more disagreements and more 
dissatisfaction with services they received (64, 65), reflecting poor PPP with their service 
providers. In a study done in the USA, to asses role of parental education, empowerment and 
professional partnerships, and on service delivery outcomes in children with ASD, high PPP was 
associated with greater service adequacy and number of services received and explained 
>12.8% variance of service adequacy above and beyond the controls (107). Similar findings 
were reported by Parish and colleagues (2012), when looking at the effect of health care quality 
on service utilization in Latino families: collaboration, culture sensitivity, and time spent with the 
child were significant mediators of the relationship between ethnicity and health care utilization 
(154). Family choices and use of services can be related to health care access and quality (106). 
A few studies have assessed health systems challenges in children with NDD in low income 
countries. In Nigeria, Bakare and colleagues (2009) reported low knowledge level among health 
workers on existing services and laws governing services for children with special needs (120). 
Subsequently, Bakare and colleagues (2009b) observed that diverse false perceptions were 
held by health workers on aetiology, treatability and preventability of childhood ASD (155). In 
Kenya, Gona and colleagues (2015) reported that among teachers, clinicians and social 
workers, supernatural causes, witchcraft and curses were considered as possible causes of 
ASD, and treatments ranged from traditional healing and spiritual healing to modern treatments 
(131). In study done in SA by Saloogee and colleagues (2007) to asses unmet health, welfare 
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and educational needs of disabled children, lack of money, limited awareness about available 
services and bureaucratic obstacles were the main reasons offered by caregivers for not 
accessing care (54). Therefore, literature from the in high income countries suggests that 
households with children with ASD report worser patient experiences and low satisfaction in 
health care, which impacts subsequent decisions in care seeking.  However, despite varied 
perceptions and knowledge level among health workers in low resourced countries, there is 
limited information on how this affects service use in children with NDD.  
  
1.7.7 Summary of gaps in literature 
Most literature on HSU in children with NDD originates from high income countries where health 
and support system are substantially better supported compared to low income counties. 
Individual, family, and contextual variables contribute to health service usage. The divergent 
clinical profiles and comorbidity patterns in these groups have been shown to impact HSU. Most 
literature describes increased HSU by children with ASD, compared to those with other NDD, 
but substantial disparities were observed among minority groups and socially disadvantaged 
communities. Family perspectives and stress level have also been shown to influence service 
use. Low income countries are facing a rising disease burden and service demands, but 
availability of services remains limited. Low level of knowledge, cultural barriers and stigma are 
still rampant among communities, as well as among service providers. High use of psychotropics 
medications and CAM therapies has been demonstrated widely. Very few studies have 
evaluated how these variables impact HSU among children with NDD in LMIC. Inadequate data 
makes much of the proposed conclusions and statements made here conjectural. There is need 








CHAPTER 2.0 METHODOLOGY 
2.1 Study design 
A retrospective cohort study was conducted.  We enrolled pre-school children with a primary 
diagnosis of ASD and those with GDD (non-ASD) attending services at a tertiary hospital at a 
ratio of 1:1. At enrolment, the child’s diagnosis was taken as what was documented in their 
medical record. HSU was determined by retrospectively reviewing their medical record visits in 
the preceding 1 year.  
2.2 Settings 
The study was done at the Red Cross War Memorial Children’s Hospital (RXH), a leading tertiary 
public health facility in the Western Cape province of South Africa. The developmental service 
is a multidisciplinary service that manages children with diverse neurodevelopmental disorders 
and other multisystemic disorders with comorbid developmental disorders. The service operates 
about 60 clinics per month, covering neurodevelopmental and cerebral palsy clinics. The unit 
serves up to 4000 visits annually, of which 1500 are non-cerebral palsy NDDs, and a third of 
these have ASD.  The service assists with establishing government guidelines aimed towards 
optimal care in a resource poor setting. 
In addition, the hospital also runs a general paediatric emergency department service on 24-
hour basis and offers primary care services. The hospital also offers rehabilitation services and 
various support services. The centre receives referrals from various community day hospitals 
(CDH), and private health facilities within their catchment area in the Western Cape province.  
Following the initial assessments, children are often sent back to the referring centre for their 
therapy needs. The system offers at least of one therapy session per child monthly, for each of 
the core services needed, as the routine standard of care. 
2.3 Variables 
 2.3.1 The dependent variables 
The dependent variable was annual frequency of HSU, covering outpatient visits for core 
therapy, specialists, emergencies, and primary care visits, and hospitalizations. The secondary 
dependent variable was unmet health care needs. 
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2.3.2 The independent variables 
The independent variables included household characteristics; socio-demographic, economic, 
perspectives, level of satisfaction and family stress level and child factors including primary 
diagnosis, disease severity, comorbidities, medication use, and CAM use.  
 
2.4 Study population 
The study population were preschool children aged 3-8 years, residing in the Western Cape 
province, and within the RXH catchment area, and who were referred to the developmental 
service for assessment, and had been diagnosed with either ASD or GDD.  
2.5 Study participants and sampling methods 
2.5.1 Sample size determination. 
A sample size of 240 was used. Sample size calculations was specific to each main outcome, 
with alpha=0.05 throughout, and equal numbers of children with GDD and ASD (1:1) in the 
sample. The primary outcomes for hypothesis testing were number of health care visits over 
preceding 12 months covering the overall annual visits and within the subgroups of core therapy, 
specialist visits, emergency visits, primary care visits and hospitalization 
Sample size calculations were given for each category based on assumptions for mean 
(standard deviation) number of visits per annum. As data for expected number of visits overall 
and within subgroups is limited for this context, several assumptions were made and variations 
in power projected by differences in assumption. A sample size of 240, was calculated to provide 
90% power to detect a mean difference of ≥ 5 overall visits comparing ASD to GDD, assuming 
a greater standard deviation (15). 
2.5.2 Sampling methods. 
Purposive sampling was done. We enrolled consecutive eligible children attending the 
developmental services who meet the inclusion criteria. Sampling continued till the desired 
sample size was attained.  
2.5.2.1 Inclusion criteria 
Preschool children aged 3-8 years attending the developmental services at the RXH, whose 
medical record indicated a primary diagnosis ASD (with or without other comorbid NDD, such 
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as GDD/ID, ADHD, learning problems), and those with a diagnosis of GDD (non-ASD), whose 
parents/caregiver consented to participating in study. Families with more than one eligible child 
were interviewed only once. 
2.5.2.2 Exclusion criteria 
The study excluded children with missing medical records, those that had been hospitalised, 
those not accompanied by the primary caregiver, institutionalized children, those with visual or 
auditory impairments, Down syndrome, and those whose parents/caregiver declined to give 
consent to participate in study. 
2.5.3 Sampling procedures 
Parents and/or caregivers were made aware of the research through posters in the waiting area. 
We sampled cases from children attending their scheduled appointments at the clinic. The 
researcher was not involved in the patient care during enrolment days. The researcher reviewed 
the medical records of all booked children and identified those eligible. These were then flagged 
to the research assistants, by a sticker placed on the folder. After completing their consultation 
session with the primary doctor, the research assistants approached those eligible and explained 
to them about the research study and sought consent. Those fulfilling the inclusion criteria were 
then ushered to a private room, where they were interviewed by the researcher, and were 
assisted to complete the questionnaire. Those who declined participation were reassured that 
there would be no penalty for non-participation. 
2.6 Data collection techniques 
Primary diagnosis 
Evaluation and diagnosis of all children referred to the clinic is routinely done by a developmental 
paediatrician, and their findings documented in the child’s medical record. The DSM-V diagnostic 
criteria was used to establish the diagnosis of ASD. This was a clinical diagnosis based on the 
child fulfilling all three categories of deficits in communication, social interactions, restricted 
repetitive behaviours, attitudes, and interests and/or abnormal sensitivity to stimuli. Children with 
ASD who had other comorbid NDD such as GDD/ID or ADHD were included. The diagnosis of 
GDD was based on the child having delays of more than 6 months compared to their chronologic 
age, in at least 2 domains of functioning, namely cognitive, motor, fine motor, language and 




Individual data collection was captured using a data extraction template. This was facilitated 
through 2 separate processes; Information about the child’s diagnosis, clinical profile, and 
treatments were extracted from the child’s medical records at the RXH. Attendance dates were 
verified with the hospital appointment records. Visits done to CDH was extracted from the 
appointment cards of the respective facilities. Verification was done during the face-to-face 
interviews. A structured questionnaire (Appendix 1) administered to the caregivers sought the 
following information: 
i. Socio-demographic factors 
These included household characteristics covering age, gender, ancestry, residence, family 
income, family characteristics, language spoken, education level, occupation of primary carer, 
carer supports and child characteristics. 
ii. Clinical diagnoses and ongoing treatments 
Diagnosis: Child’s primary diagnosis, age at first diagnosis, duration since diagnosis, disease 
severity and immunization status were obtained from the medical records, including the patient-
held Road-To-Health Booklet. 
Co-morbidities: Any underlying syndromic diagnosis, comorbid medical problems and 
psychiatric diagnoses occurring in last 1 year, were obtained from the medical record, and as 
per parental self-report. Psychiatric and behavioural comorbidities considered included ADHD, 
anxiety, depression, intellectual disability, conduct disorders, elopement, and self-injurious 
behaviours. Occurrence of any emergency events in the previous 1 year were also documented. 
Medications and CAM use: Use of psychotropics or other CAM therapies was established from 
history and/or from medical records. These covered psychotropics, anticonvulsants, melatonin, 
homeopathic remedies, supplements, and special diets such as gluten free or casein free diets.  
iii. Family perceptions, distress, experiences, and satisfaction level assessments 
‘The brief illness perception questionnaire’ (brief IPQ), was used to asses caregiver perspectives 
(156). This tool has been validated for use in diverse chronic illnesses.  It was adapted for our 
local settings. The tool identifies 8 dimensions within the cognitive representation of illness as 
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follows; 1) Consequences describes the expected effects and outcome of the illness,  2) Timeline 
describes how long the patient believes the illness will last, 3) Personal control  describes the 
extent to which patient believes that they have control over the illness, 4) Treatment control 
describes the extent to which patient believes that the treatment can control the illness, 5) 
Identity, describes how much the person experiences the symptoms of illness, 6) Concern 
describes how much the patient is concerned about illness, 7) Understanding describes how 
well the patient understands the illness, 8) Emotional response describes how much the illness 
affects them emotionally. The brief IPQ uses a single item scale approach to access perceptions 
in a continuous linear scale. Each dimension was scored on a scale of 0-4, with 0 as lowest and 
4 as highest agreement, and the mean for each domain determined. 
‘The brief family distress scale for autistic children’ (157) was used to assess family distress 
level.  Caregivers were asked to rate their level of stress on a scale of 1-10, with 1 as lowest 
score and 10 as the highest level of stress. 
‘The brief questionnaire for assessing health care experiences (158) was used to asses 
caregiver experiences in health settings, with some local adaptations. Parents were required to 
rate their overall experiences during services accessed at the RXH and at the CDH on a Linkert 
scale of 0-4, where  0 = not satisfied, 1= somewhat dissatisfied, 2= somewhat satisfied, 3= 
satisfied, 4= very satisfied. The 5 subscales assessed included communication with therapist, 
communication with doctors, physical environment, management of disruptive behaviours at 
facility, and treatment communications by providers. 
 
‘The short- form patient satisfaction questionnaire’ (PQS-18) (159) was used to assess client 
satisfaction with services. Parents were required to rate various services provided at the RXH 
and at the CDH, by stating how well their expectations were met, using a Likert scale of 1-5 (1= 
not satisfied, 2= unknown, 3= somewhat satisfied, 4= satisfied, 5= very satisfied), by responding 
to 18 questions covering 7 subscales; general satisfaction, technical quality, interpersonal 
manner, communication, financial status, time spent with doctor, accessibility and convenience, 





Outcome measures  
The primary outcome was the annual frequency of health service utilization, overall and within 
the sub-type of health care. Service areas covered included (1) core therapy visits, (2) specialist 
services, (3) emergency visits (4) primary care visits, and (5) hospital admissions attended in 
the previous 1 year. 
Core therapy visits: Annual frequency of visits for physiotherapy, occupational therapy and 
speech and language therapy, was determined and corroborated by child’s medical records. 
Annual attendance for ancillary support services such as social worker, counselling services, 
dietician, electrophysiology, and audiology services was determined.  
Specialist visits: Visits to specialist clinics including developmental, neurology, psychiatry, 
genetics, allergy, gastroenterology, cardiac, surgical, dental, and other services in the previous 
year were documented.  
Emergency visits: Frequency of visits to emergency department in previous year was 
documented. Parents were asked to state place where emergency services were sought, 
preferred point of services in emergencies, and whether child required admission.  
Primary care visits: Families were asked to state if they attended any routine health supervision 
/vaccination clinics in the previous year and the type of services they had received. Verification 
was done by checking the Road-to-Health Booklet.  
Hospitalizations – The number of in-patient admissions for more than 24 hours in preceding year  
at the RXH or any other hospital, was determined from the medical record, and by patient 
reports. 
Unmet needs - These included services required but no appointment had been issued, or  
scheduled appointments that were missed for whatever reason, or therapy services missed, 
based on  a minimum standard of once monthly schedules, but were not accessed.  
2.7 Validity 
All questionnaires used in the study including: the brief illness perception questionnaire, the brief 
family distress scale, the brief questionnaire for assessing health care experiences, the short-
form patient satisfaction questionnaire have all been previously validated (156-159). ‘The brief 
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illness perception questionnaire’ has been used in diverse chronic illnesses by Broadbent and 
colleagues (156). Specifically, use in autism was validated by Mire and colleagues (2018) in the 
USA (160). The patient satisfaction questionnaire has been shown to be adaptable, reliable, and 
validated tool for use in various settings by Thayaparan and colleagues (2013) in the United 
Kingdom (161). The brief questionnaire for assessing health care experiences in low income 
settings was validated by Webster and colleagues (2011) in Ethiopia (162). 
 
The complete set of questionnaires were assembled into one unit and piloted on 5 mothers to 
identify potential ambiguities that needed to be addressed, and thereafter translation into 
isiXhosa and Afrikaans was done. Back-translated questionnaire were compared with the 
original questionnaire by an independent professional proficient in both languages. 
2.8 Reliability 
The final questionnaire was piloted on 10 participants to ascertain readability by layman level 
readers, clarity, and time of survey completion. Recruitment started by folder review by the 
researcher, to identify those eligible, by putting a sticker on their folders. Two research assistants 
who are qualified nurses assisted in the consenting of eligible respondents. Those caregivers 
that consented were requested to fill the questionnaires, and further interviewed by the 
researcher. For those with any missing data, the parent /caregiver was telephonically contacted 
to provide the information within 2 weeks of first interview. 
2.9 Data Analysis 
Exploratory analyses evaluated distributional properties of the main outcomes overall and within 
subgroups, including: 
(i) Count data for number of health care visits, overall and within subgroup of type of care 
(ii) Proportion of children with unmet health care needs 
(iii) Proportion of caregivers with high levels of satisfaction with health care 
The main comparison groups were ASD vs GDD. Standard exploratory data techniques (EDT) 
were used to assess relationships between potential third variables and both the outcome and 
main exposure variables. Descriptive statistics were computed describing the sociodemographic 
characteristics, economic status, comorbid states, emergency conditions, functional level, 
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medication use and parent perspectives, experiences, family distress level and service 
satisfaction level. In exploratory data analysis (EDA), health care visits were expressed as mean 
(standard deviation, SD), where normally distributed (difference in means compared with 
Student’s t-test); or median (interquartile range, IQR) where skewed (equality of medians tested 
with Kruskal-Wallis). Categorical variables were compared with the Chi2 statistic. Summary data 
has been presented in tables, pie charts and bar graphs. A modified version of Andersen’s 
Behavioural Model of Health service (56) was used to group the variables into 3 categories; 
predisposing factors, enabling factors and need variables. The primary analysis used bivariable 
and multivariable linear regression to compare mean difference in visits between children with 
ASD and those with GDD (expressed as crude and adjusted beta coefficients representing mean 
difference in numbers of visits, with 95% confidence intervals). Multivariable models were used 
to adjust for confounders and test for effect modification of the main comparison (ASD vs GDD) 
by child sex, age group and maternal socio-economic status. Analyses were done in Stata 
version 14.0 (Stata Corps, College Station, TX); all p-values are two-sided.   
 
2.10 Logistical and ethical considerations 
Ethical approval for the study was obtained from the University of Cape Town, Faculty of Health 
Sciences Research Ethics Committee (HREC REF:397/2019) (Appendix 4) Approval was 
sought from RXH management where the study was conducted (Appendix 5). The study 
complied with the Declaration of Helsinki (2013). Written consent was sought from the 
parent/legal guardians to participate in study (Appendix 2). Strict confidentiality and privacy were 
observed during interview and data handling. Parents were free to decline participation without 
any repercussions. All children received the minimum recommended care during the study. Data 
was coded into a computer software program. Study findings will be published to benefit other 
















CHAPTER 3 RESULTS 
3.1 Introduction                                            
This section presents study findings under the following 6 subheadings: Sociodemographic 
characteristics, economic characteristics, child characteristics, family perceptions, family 
distress, experiences, and level of satisfaction and health service usage patterns. The effect of 
various family and child factors on HSU are then described. 
3.2 Sociodemographic characteristics of study population 
A total of 240 caregiver-child dyads were enrolled, 116 had ASD and 124 had GDD (Table 1). 
Caregiver’s age ranged from 19- 58 years. Overall, the biologic mother was the primary caregiver 
for majority, (86%, 206/240) of the families. Regarding their marital status, 86/240 (36%) of the 
primary caregivers were single or separated from their spouses. While most (202/240, 84%) 
families interviewed were South African nationals, 16% (38/240) were foreign nationalities. The 
language spoken at home was predominantly English (91/240, 38%) or Afrikaans (90/240,37%). 
Most (204/240, 85%) of the primary caregivers had less than tertiary level of education. As 
pertains to availability of social support systems for these families, 79/240 (33%) reported having 
no other social supporter that could assist in bringing the child to the hospital in event of absence 
of the primary caregiver, and only 16% (38/240) having consistent support. Regarding any travel 
out of Western Cape province during the study period, majority (212/240, 88%) of the families 
reported having been away for a period of no more than 2 weeks in the preceding 1 year 
Comparing the demographic characteristics of the two groups, they were found to be similar in 
most aspects, except for the availability of some social support, which was slightly higher in 
families with children with ASD, compared to those with GDD (86/116, 75% vs 74/124, 60%; 








     TABLE 1. Socio-demographic characteristics of study population by child primary     
          diagnosis 







Age of primary 
carer (years) 
< 25 15 (6%) 9 (8%) 6 (5%)  
 
0.77 
25 - 30 81 (34%) 41 (35%) 40 (32%) 
31 - 35 66 (28%) 33 (28%) 33 (27%) 
36 - 40 34 (14%) 14 (12%) 20 (16%) 
41 - 45 28 (12%) 13 (11%) 15 (12%) 





206 (86%) 101 (87%) 105 (85%) 
0.66 
Foster mother 12 (5%) 7 (6%) 5 (4%) 
Aunt 7 (3%) 3 (3%) 4 (3%) 
Grandmother 14 (6%) 5 (4%) 9 (7%) 
Other 1 (<1%) 0 1 (1%) 
Marital status Married or 
cohabiting 
154 (64%) 80 (69%) 74 (60%) 
 
    0.13 
Single or 
separated 
86 (36%) 36 (31%) 50 (40%) 
Nationality South African 202 (84%) 93 (80%) 109 (88%) 
0.10 
Other  38(16%) 23 (20%) 15 (12%) 
Ancestry White 14(5.0%) 7(6.0%) 7(5.6%)  
0.55 Black 134(55.8%) 64(55.2%) 70(56.5%) 
Coloured 89(37.1%) 44(18.3%) 45(36.3%) 
Indian 2(0.01%) 0(0%) 2(1.6%) 
Other 1(0.004) 1(0.01%) 0(0%) 
Home language English 91 (38%) 49 (42%) 42 (34%) 
0.49 
Afrikaans 90 (37%) 43 (37%) 47 (38%) 
Xhosa 42 (18%) 16 (14%) 26 (21%) 





204 (85%) 96 (83%) 108 (87%) 
 
0.35 
Tertiary 36 (15%) 20 (17%) 16 (13%) 
Caregiver has a 
social supporter 
to accompany to 
hospital visits 
None 79 (33%) 29 (25%) 50 (40%) 
0.04 
Sometimes 122 (51%) 64 (56%) 58 (47%) 
Always 38 (16%) 22 (19%) 16 (13%) 
Time spent away 
from Cape Town 
in previous year 
Never left Cape 
Town 
180 (75%) 86 (74%) 94 (76%) 
0.99 < 2 weeks away 32 (13%) 16 (14%) 16 (13%) 
2-4 weeks away 18 (8%) 9 (8%) 9 (7%) 
> 4 weeks away 10 (4%) 5 (4%) 5 (4%) 
       Numbers are n (column %) or median (interquartile range); p-values obtained from Chi2 test for categorical and Kruskal-Wallis 
       test for equality of medians for continuous variables 
       All variables in this table represent data obtained from questionnaires completed by attending caregiver 
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3.3 Household economic characteristics of study population 
Overall, families of children included in this study reported several economic challenges (Table 
2). Overall, only 85(35%) of the 240 families had either the father or mother in formal 
employment, either on part-time or full-time engagement (Figure 1 and Table 2). Most families 
(210/240, 87%) reported a monthly income below R8000 South African rand (~ US$ 2020); 42% 
(100/240) lived in low-income neighbourhoods. The majority (170/240, 71%) of households used 
public transport to come to hospital, with some requiring the train service for part of the distances. 
Accordingly, the median travel time was 2 hours (IQR 2-2, indicating that at least 75% of the 
families travelled 2 hours), with most families requiring <R100 transport costs per hospital visit 
(91%, 219/240). A fifth of families (49/240, 20%) reported not receiving any governmental 
support for their child; 63% (151/240) were receiving the state paid childcare dependency grant, 
while 14% (34/240) were on social security for support (table 2). 
Across measures, families of children with ASD tended to report more economically secure 
situations than families of children with GDD. This included higher employment rates (ASD vs 
GDD, 42% vs 29%; p= 0.03); and a higher likelihood of using their own car or a private (more 
expensive than public) taxi (ASD vs GDD: 38/116, 33% vs 23/124, 19%; p=0.008). Families of 
children with ASD were also marginally more likely to have an income of ≥R8000 than those of 
children with GDD (19/116,16% vs 11/124, 8%; p=0.08). Travel costs, time spent travelling and 
grant receipt did not differ by child primary diagnosis (table 2)  
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      TABLE 2. Household economic characteristics of study population by child primary    

















father have formal 
employment 





Neither mother nor 
father have formal 
employment 










30 (13%) 19 (16%) 11 (9%) 
Type of 
neighbourhood 
Low income 100 (42%) 40 (34%) 60 (48%)  
0.08 Middle/high 
 income 
140 (58%) 76 (66%) 64 (52%) 




<R100 or unknown 219 (91%) 107 (92%) 112 (90%) 
0.60 
≥R100 21 (9%) 9 (8%) 12 (10%) 
Means of 
transport 
Walk 9 (4%) 5 (4%) 4 (3%) 
0.008 
Public  170 (71%) 73 (63%) 97 (78%) 
Own car 49 (20%) 34 (29%) 15 (12%) 
Private taxi 12 (5%) 4 (4%) 8 (7%) 




Mean time required 
to travel from home 
to hospital 
 







State paid 191 (80%) 90 (78%) 101 (81%) 
0.83 
Medical aid 28 (12%) 14 (12%) 14 (11%) 
Private insurance 6 (2%) 3 (3%) 3 (2%) 





None 49 (20%) 23 (20%) 26 (21%) 
0.25 
Social security 33 (14%) 15 (13%) 18 (14%) 
Childcare 
dependency 
151 (63%) 72 (62%) 79 (64%) 
Other  7 (3%) 6 (5%) 1 (1%) 
       Numbers are n (column %) or median (interquartile range); p-values obtained from Chi2 test for categorical and Kruskal-Wallis 
       test for equality of medians for continuous variables 
       All variables in this table represent data obtained from questionnaires completed by attending caregiver 
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 3.4 Child characteristics and diagnostic features 
Overall, the children’s age ranged from 3-8 years, with male: female ratio of 2:1 (Table 3). 
Majority, (157/240, 65%) were the only child in the household. Overall, most (145/240, 60%) had 
moderate disease severity.  Parental concern was raised before the age of 3 years in 174/240, 
72%), while in 66% (159/240) were first diagnosed before the age of 3 years. We reported 
syndromic diagnoses in 57/240 (24%), concurrent comorbid diagnoses in 65/240 (27%), and 
82/240 (34%) were non-verbal. Most children (176/240;73%) were up to date on their 
immunizations.  
As expected, there were some marked differences in clinical and diagnostic characteristics 
between children with ASD and children with GDD. Children with GDD were diagnosed at an 
earlier age than those with ASD (p=0.0001). Though the functional severity of the underlying 
condition was similar in both groups, higher co-occurring syndromic diagnoses were reported in 
those with GDD than ASD, (46/124, 37.1% versus 14/116, 9.5%); (p=0.0001), as well as more 
comorbid chronic medical conditions were reported in those with GDD than ASD (51/124, 41.0% 
vs 14/116, 12.1%); (p=0.0001) (Figure 2). More children with ASD had <10-word vocabulary at 
62.9% (73/116), compared to 43.5% (58/124) with GDD (p=0.01). Though the use of prescription 
medications were similar in both groups, use of anticonvulsant medications was greater in those 
with GDD than ASD (16/124,13.0% vs 4/116, 3.0%); (p=0.008). However, use of CAM therapies 






      

















































       TABLE 3. Child characteristics and diagnostic features by primary diagnosis 








Child age ≥ 2 < 3 years 28 (12%) 12 (10%) 16 (13%) 0.41 
≥ 3 < 4 years 29 (12%) 11 (9%) 18 (15%) 
≥ 4 < 5 years 42 (17%) 23 (20%) 19 (15%) 
≥ 5 < 6 years 71 (29%) 40 (34%) 31 (25%) 
≥ 6 < 7 years 45 (19%) 20 (17%) 25 (20%) 
≥ 7 years 25 (10%) 10 (9%) 15 (12%) 
Gender Male 164 (68%) 87 (75%) 77 (62%) 0.03 




Only child 157 (65%) 71 (61%) 86 (69%) 0.19 
Has siblings 83 (35%) 45 (39%) 38 (31%) 
Severity of 
illness 
Level 1, Mild 38 (16%) 17 (15%) 21 (17%) 0.58 
Level 2, Moderate 145 (60%) 74 (64%) 71 (57%) 
Level 3, Severe 57 (24%) 25 (21%) 32 (26%) 
Time of onset of 
parental 
concern 
<3 years 174 (72%) 81 (70%) 93 (75%) 0.37 
>3years 66 (28%) 35 (30%) 31 (25%) 
 Age at first 
diagnosis 
< 1 year old 46 (19%) 8 (7%) 38 (31%) <0.0001 
≥ 1 ≤ 2 years old 57 (24%) 26 (22%) 31 (25%) 
> 2 ≤ 3 years old 56 (23%) 30 (26%) 26 (21%) 
> 3 ≤ 4 years old 55 (23%) 35 (30%) 20 (16%) 
> 4 ≤ 5 years old 25 (10%) 16 (14%) 9 (7%) 




None 183 (76%) 105 (90%) 78 (63%) <0.0001 
Genetic 36 (15%) 8 (7%) 28 (23%) 
Metabolic 2 (1%) 0 2 (2%) 
Hormonal 3 (1%) 1 (1%) 2 (2%) 
Structural defects 4 (2%) 1 (1%) 3 (2%) 
Other 12 (5%) 1 (1%) 11 (9%) 
Concurrent 
comorbidity 
None 175 (73%) 102 (88%) 73 (59%) <0.0001 
Asthma 10 (4%) 4 (3%) 6 (5%) 
HIV 5 (2%) 1 (1%) 4 (3%) 
Tuberculosis 2 (1%) 0 2 (2%) 
Seizures 18 (8%) 3 (3%) 15 (12%) 
Other 30 (12%) 6 (5%) 24 (19%) 
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    TABLE 3 (Continued)  








Verbal ability Non-verbal 82 (34%) 45 (39%) 37 (30%) 0.01 
< 10 words with 
meaning 
49 (20%) 28 (24%) 21 (17%) 
10-20 words with 
meaning, no 
phrases 
53 (22%) 26 (22%) 27 (22%) 
> 20 to 30 words 
with meaning, 2-3 
phrases 
29 (12%) 6 (5%) 23 (19%) 
> 30 words with 
meaning, 
sentences 
27 (11%) 11 (9%) 16 (13%) 
Immunization 
status 
Up to date 176 (73%) 82 (71%) 94 (76%) 0.42 
Missed some 39 (16%) 18 (16%) 21 (17%) 
No recorded 
vaccinations 
12 (5%) 8 (7%) 5 (4%) 





agents (vs none) 
20 (8%) 4 (3%) 16 (13%) 0.008 
Any psychotropics 
(vs none) 




(vs no other) 





173 (72%) 83 (72%) 90 (73%) 0.73 
Dairy restrictions 
 
16 (7%) 9 (8%) 7 (6%) 
Other dietary 
restrictions 
33 (14%) 14 (12%) 19 (15%) 
Supplements 
 
4 (2%) 3 (3%) 1 (1%) 
Other 
 
14 (6%) 7 (6%) 7 (6%) 
           Numbers are n (column %) or median (interquartile range); p-values obtained from Chi2 test for categorical and  
           Kruskal-Wallis test for equality of medians for continuous variables. All variables in this table represent data obtained from        








3.5 Family perceptions, stress level, experiences, and level of 
satisfaction 
‘The brief illness perception questionnaire’ (Brief IPQ) (156) rated 8 cognitive 
dimensions on a scale of 0-4. Overall, highest (163) rating was on “consequences” at 
4, while the lowest rating was on “treatment control” and “understanding” dimensions, 
which were rated at 2. Ratings were similar in both ASD and GDD groups, except for 
the “understanding” dimension where the families of children with ASD rated it the 
lowest at 1 (Table 4). The components of the perception scores with medians and 
interquartile range are presented in Figure 2. 
 
Figure 3. Box-and-whiskers plots showing median (interquartile range) of scores for 
components of the Brief IPQ as completed by caregiver, by child primary diagnosis 































Consequences (p=0.48) Time-line (p=0.31)
Personal control (p=0.60) Treatment control (p=0.27)
Identity (p=0.90) Concern (p=0.78)








The mean score for this cohort on ‘The brief family distress scale for autistic children’ 
(157) was 3.3 out of 10 (SD 1.2). This score means that things are often stressful, but 
they were able to cope with problems as they arose. There was no difference in the 
mean ratings of stress level in both groups (Table 4). A few 3/116 (2.6%) families with 
ASD rated their stress level at 7, which meant that things were so bad for them and 
they would soon be in a crisis and they required referral to a family counsellor. 
 
Parents rated 5 subscales on ‘The brief questionnaire for assessing health care 
experiences scale’ (158), using a Linkert scale of 0-4. Overall, the highest ratings were 
in communication with doctors and communication with therapists, both of which were 
rated at 4 out of 4, while the ratings for physical environment, management of 
disruptive behaviour and treatment communication of the home therapies were all 3 
out of 4. There were no meaningful differences observed between families with 
children with ASD or those with GDD (Table 4).  
Ratings on the ‘Patient satisfaction questionnaire-18’ (PSQ-18), were generally higher 
at RXH compared to CDH, but the average rating of the 2 sites was used in the 
analysis. Caregivers responded with mostly positive scores across domains (mean 
score above 3.5), except for financial status (mean score 3.4, SD 0.7), time spent with 
doctor (mean score 2.9, SD 0.7), and accessibility/ convenience (mean score 2.7, SD 
0.1). High satisfaction (>80%), was reported in 8% (9/124) of families with children 
with GDD and 10% (12/116) of those with ASD. There were no differences by child 















TABLE 4. Qualitative measures (caregiver perspectives, family stress, health care 
experiences and level of satisfaction) comparing families of children with primary 
diagnosis of autism spectrum disorder (ASD) to those of children with primary 
diagnosis of global developmental delay (GDD) 
Scale name and items 
Total 
     (N=240) 
GDD 
     (N=124) 
ASD 
     (N=116) 
Absolute 
difference 
(GDD- ASD) in 
means (95% CI) 
p-value  
Brief illness perspective 
questionnaire (B-IPQ)1 
     
Consequences2 4.0 (3.0; 4.0) 4.0 (3.0; 4.0) 4.0 (3.0; 4.0) n/a 0.48 
Timeline 3.0 (3.0; 4.0) 3.0 (3.0; 4.0) 3.0 (3.0; 4.0) n/a 0.31 
Personal control 3.0 (2.0; 3.0) 3.0 (2.0; 3.0) 3.0 (2.0; 3.0) n/a 0.60 
Treatment control 2.0 (2.0; 3.0) 2.0 (2.0; 3.0) 2.0 (1.0; 3.0) n/a 0.27 
Identity 3.0 (2.0; 3.0) 3.0 (2.0; 3.0) 3.0 (2.0; 3.0) n/a 0.90 
Concern 3.0 (2.0; 4.0) 3.0 (2.0; 4.0) 3.0 (2.0; 4.0) n/a 0.78 
Understanding 2.0 (1.0; 3.0) 2.0 (1.0; 3.0) 1.0 (1.0; 2.5) n/a 0.18 
Emotional response 3.0 (2.0; 4.0) 3.0 (2.0; 4.0) 3.0 (2.0; 4.0) n/a 0.26 
Brief family distress 
scale3 




Experiences in Health 
Services4 
     
Communication with 
therapist 
4.0 (3.0-4.0) 4.0 (3.0-4.0) 4.0 (3.0-4.0) n/a 0.73 
Communication with 
doctor 
4.0 (3.0-4.0) 4.0 (3.0-4.0) 4.0 (3.0-4.0) n/a 0.30 
Physical environment 3.0 (3.0-4.0) 3.0 (3.0-4.0) 3.0 (3.0-4.0) n/a 0.77 
Management of 
disruptive behaviour 
3.0 (3.0-4.0) 3.0 (3.0-4.0) 3.0 (3.0-4.0) n/a 0.86 
Therapy communication 3.0 (3.0-4.0) 3.0 (3.0-4.0) 3.0 (3.0-4.0) n/a 0.37 
Patient satisfaction 
questionnaire (PSQ-18)5 
     
General satisfaction 3.6 (0.6) 3.6 (0.6) 3.6 (0.6) 0.0 (-0.2; 0.2) 0.96 
Technical quality 3.8 (0.6) 3.8 (0.6) 3.8 (0.6) 0.0 (-0.2; 3.9) 0.80 
Interpersonal manner 3.7 (0.7) 3.7 (0.7) 3.6 (0.6) 0.1 (-0.04; 0.3) 0.13 
Communication 4.1 (0.6) 4.1 (0.6) 4.1 (0.6) 0.0 (-0.1; 0.2) 0.77 




Time spent with doctor 2.9 (0.7) 3.0 (0.7) 2.9 (0.6) 0.1 (-0.1; 0.2) 0.53 
Accessibility and 
convenience 
2.7 (0.1) 2.8 (0.8) 2.7 (0.8) 0.1 (-0.1; 0.3) 0.41 
Satisfaction overall6 23.9 (2.9) 24.1 (3.0) 23.8 (2.9) 0.3 (-0.5; 1.0) 0.51 
Proportion with high 
overall satisfaction 
(total score ≥ 28) 









                   Unless otherwise indicated, values are median (interquartile range) for variables with skewed distribution (p-values from       
                   Kruskal-Wallis test) or mean (standard deviation) for variables with normal distribution (presented in summary  
                  and with difference in means, p-values from t-test without ties) 
                          1 Scale ranges from 0 to 4, with 4 indicating strongest effects 
                          2 Missing data: n=1 
                          3 Scored from 1 to 7, with 1 “Everything is fine. Not in a crisis at all”, and 7 “Things were so bad for them and they would    
                    soon be in a crisis” 
                        4 Scale ranges from 0 to 4, with 0 “Not satisfied” and 4 “Very satisfied; therefore, higher scores indicate  
                  better experiences with health care components 
                        5 Scale ranges from 1 to 5, with 1 “Strongly disagree” to 5 “Strongly agree”; therefore, higher satisfaction is  
                  associated with higher score; for analysis purposes, all non-integers rounded up 
                        6 Overall score from addition of 7 levels, therefore highest possible score is 35 and higher scores indicate   
                   greater overall satisfaction 
                        7 “High satisfaction” defined as having at least 28 overall score (28/35, 80%); that is, a minimum of 4 for all 7   

























3.6 Health Service utilization patterns 
The overall mean annual frequency of health care visits for this cohort was 12.4 (SD 
5.7) visits per child per annum (Table 3). However, higher mean annual frequency of 
service use was observed for families with GDD (13.3 visits) compared those with ASD 
(11.5 visits), p=0.02. This primarily reflected differences in the number of specialist 
visits, with a higher annual mean frequency among children with GDD, 4.0 (2.0-5.5) 
compared to those with ASD 2.0 (2.0-3.0) (p<0.0001). The mean annual visits for other 
services were similar in both groups, including core therapy 6.0 (2.0-10.0), axillary 
services 0 (0-1.0), emergency visits 1.0 (1.0-2.0), and primary care visits 0 (0-1.0).   
Thirty-six (15.0%) children in this cohort did not attend any therapy in the preceding 
year, with similar proportions among those with GDD19/124(15.3%) and those with 
ASD 16/116(13.7%), (p=0.88). For those accessing therapy, frequency of visits ranged 
from 1-18 visits per child. Regarding access of auxiliary services, 37(29.8%) of 
households with children with GDD versus 27(23.3%) with children with ASD had 
accessed at least one of these services in previous year. Overall, 103/240 (42.9%) of 
the children in this cohort had attended at least 1 primary visit in the preceding year, 
comprising of 57(45.9%) with GDD versus 46(39.6%) with ASD. Emergency visits 
ranged from 0-10 visits per child per annum. While 23.4% (29/124) with GDD versus 
(22.6%) 28/124 with ASD had no emergency visits in previous year, 76.6% (95/124) 
of GDD versus 75.8% (88/116), with ASD had at least 1 emergency visit in the 
preceding year. The leading reasons for emergency visits for those with GDD were 
respiratory illness, unspecified fevers and seizures at 44/124(35.5%), 32/124(25.8%), 
24/124(19.4%) respectively, whereas in the ASD group, was respiratory illness, 
unspecified fevers, and gastrointestinal problems at 47/116(40.5%), 25/116(21.5%) 
and 16/112(13.7%) respectively. Overall injuries or accidents accounted for 8.7% 
(21/240), while mental and behavioural problems accounted for 5.7% (15/240) of 
reported emergency visits in this cohort. Overall, 22.5% (54/240) of children had at 
least one hospitalization in the previous year. Hospitalization was more likely among 










TABLE 5. Health care utilization over previous year, by primary diagnosis: 
comparison of mean and median numbers of overall and specific health care 

















visits (sum of all 
attended visits)1 
12.4 (5.7) 13.3 (6.0) 11.5 (5.3) 1.7 (0.3; 3.2) 0.02 
Core therapy visits2 
 
6.0 (2.0-10.0) 6.0 (2.0-9.0) 6.0 (2.0-10.0) - 0.56 
Auxiliary service 
visits3 
0 (0-1.0) 0 (0-1.0) 0 (0-0) - 0.22 
Emergency service 
visits4 
1.0 (1.0-2.0) 1.0 (1.0 -2.0) 1.0 (0.5 -2.5) - 0.51 











0 (0-0) 0 (0-1) 0 (0-0) - 0.02 
                 Numbers are median (interquartile range) visits where variable distribution is skewed (p-value from Kruskal-Wallis equality    
                 of medians test), or mean (standard deviation) with p-values from T-test and presented with difference in means (95%    
                 confidence interval) 
                1 Sum of core, auxiliary, emergency, specialist care and primary care visits 
                2 Includes physiotherapy, occupational therapy, and speech/language therapy visits 
                3 Includes appointments for audiology, social worker, family counsellor, electrophysiological monitoring and   
                    Dietician. 
4 Includes any health care visits for acute illness such as diarrhoea, pneumonia, seizures etc. 
                5 Includes neurology, neuro-developmental, genetic, ophthalmology, gastroenterology, pulmonology allergy,   
                   cardiology, surgical (including ear, nose, and throat) 
6 Includes routine vaccination and clinic -level growth monitoring 
                7 Includes admissions at any health facility for more than 24 hours. 






















3.7 Factors affecting Health Service utilization patterns 
 
Factors associated with health service utilization (number of annual health visits) are 
shown overall, and within sub-groups of primary diagnosis (GDD and ASD), in table 
6. Crude beta coefficients represent mean difference in average number of annual 
visits by comparison groups, obtained from linear regression; negative coefficients 
indicate lower annual HSU, while positive coefficients indicate higher annual HSU. 
Table 7 shows adjusted mean differences in average number of annual visits, obtained 
from multivariable linear regression.  
Overall, children with ASD had 1.76 fewer annual visits compared to those with GDD 
(β -1.76, 95% CI -3.20 to -0.32; p=0.02). Unsurprisingly, factors known to be predictive 
of a diagnosis of GDD rather than ASD (and therefore reflecting the need factors 
associated with GDD) were also predictive of higher HSU in the overall cohort. In 
epidemiological terms, these factors emerged as confounders (and consequently 
associations were lessened or no longer present once analysis was stratified by 
primary diagnoses).These included being female (vs male, average 1.59 more annual 
visits, p=0.04), being younger at first diagnosis (<2 vs ≥ 2 years, 1.72 more annual 
visits, p= 0.02), and having a concurrent syndromic diagnosis (vs none, 2.19 more 
annual visits, p=0.01). Controlling for these factors in the multivariable analysis, 
parental employment emerged as the strongest residual predictive factor for increased 
HSU (β 1.49, 95% CI -0.02 to 3.00, p=0.05), table 7. Overall, other factors (associated 
with higher HSU) included marital status (married vs single/separated, β 1.61, 95% CI 
0.11 to 3.11; p=0.04; a predisposing factor), and caregivers’ higher belief that therapy 
was able to control the illness (“Treatment control”, per unit increase in score: β 1.04, 
95% CI 0.38 to 1.76, p=0.003). Figure 2 shows the median (IQR) annual visits over 
treatment control categories (4 being indicative of higher perception of treatment 
control).  
Most of the bivariable associations noted between predictors and HSU in the overall 
group analysis (table 4a) were not consistently associated with HSU after stratification 
(tables 4b and 4c), suggesting some confounding (addressed above) and some effect 
measure modification by primary diagnosis. Therefore, the following associations are 








Among children with GDD (Table 4b), the primary enabling factor associated with 
increased HSU was parental employment (average 2 more annual visits per year), 
while the primary needs factor was a concurrent syndromic diagnosis (almost 2 more 
annual visits per year), although estimates had limited precision. 
Among children with ASD, families who paid R100 or more per hospital visit on 
average attended 6 more annual visits (β 5.95, 95% CI 2.47 to 9.43, p=0.0001), 
suggesting an association with higher SES levels (enabling factor), which was also 
reflected in the higher number of annual visits associated with caregiver tertiary 
education (β 2.71, 95% CI 0.17 to 5.24, p=0.04). Girls with ASD attended 3 more 
annual visits per annum than boys (p=0.04), as did children whose caregiver reported 
CAM use (p=0.005), likely reflecting needs factors related to severity of the diagnosis. 
Several psycho-social factors were associated with HSU among families of children 
with ASD. Each 1unit increase in the Brief IPQ score for personal control was 
associated with 1 more annual visit (p=0.009), and for treatment control, just under 2 
more annual visits (p<0.0001, table 4b). Similarly, a higher satisfaction score on the 
PSQ-18 patient satisfaction questionnaire predicted a greater number of health visits. 
By contrast, increasing scores on the brief family distress scale predicted lower HSU, 
with 1 fewer visit per annum per unit increase in the distress score (p=0.003). 
(Other factors assessed in bivariate analyses that were not found significant are 

















Figure 4. Box-and-whiskers plots showing health care utilization over indicator 











































TABLE 6. Factors associated with health care utilization (a) overall; (b) 
restricted to children with primary diagnosis of ASD; and (c) restricted to 
children with primary diagnosis of GDD: mean differences with 95% 
confidence intervals from linear regression 
 (a) Full cohort         
(N=240) 
(b) Children with GDD 
(n=124) 
(c) Children with ASD 
(n=116) 














   GDD (ref) 1.00 - n/a - n/a - 
   ASD 
-1.76 
(-3.20; -0.32) 
0.02 n/a - n/a - 
Presence of genetic syndrome 
    Non syndromic 1.00 - 1.00 - 1.00 - 
   Has a syndromic    










Co-occurring morbidity  
No other known chronic 
diagnosis 
1.00 - 1.00 - 1.00 - 










Age at which child received primary diagnosis 
≥ 2 years of age 1.00 - 1.00 - 1.00 - 






















Parental employment  
     Neither parent is   
     employed full-time (ref) 
1.00 - 1.00 - 1.00 - 
      At least one parent is   










Cost of travelling to and from hospital 
      <R100 (ref) 1.00  1.00 - 1.00 - 


















TABLE 6 (continued) 
 
(a) Full cohort         
(N=240) 
(b) Children with GDD 
(n=124) 















Binary income indicator 
       ≥R8000/month (ref) 1.00 - 1.00 - 1.00 - 












     Male 1.00 - 1.00 - 1.00 - 










Caregiver relationship status 
     Single/unmarried (ref) 1.00 - 1.00 - 1.00 - 










Caregiver highest level of education 
     Does not have tertiary   
     education (ref) 
1.00 - 1.00 - 1.00 - 










Caregiver reports of complementary or alternative medicines (CAM) 
No CAM use known 1.00 - 1.00 - 1.00 - 




















































Abbreviations: GDD, global developmental disorder; ASD, autism spectrum disorder; CI, confidence interval, 
Beta-coefficients represent mean difference in health care visits: comparing each category to the reference, or 








1 p-value for interaction effect of indicated variable (e.g. child sex) with binary indicator for primary diagnosis 
(GDD vs ASD) is p<0.05, indicating likely presence of effect measure modification, i.e. p<0.05 suggests that the 
relationship between indicated variable and overall health care visits varies within subgroups of primary 
diagnosis 
 
TABLE 7. Health care utilization comparing children with primary diagnosis of 
ASD to those with primary diagnosis of GDD: adjusted mean differences with 
95% confidence intervals from multivariable linear regression 
 
             Abbreviations: GDD, global developmental disorder; ASD, autism spectrum disorder; beta-coefficients represent   
             mean difference in health care visits comparing ASD to GDD (i.e. GDD – ASD)                                                                                                                                                                            









 Adjusted β coefficient1 
(95% confidence interval) 
p-value 
Primary diagnosis   
Global developmental disorder (ref) 1.00 - 
Autism spectrum disorder -1.19 (-2.73; 0.36) 0.13 
Parental employment    
Neither parent is employed full-time (ref) 1.00 - 
At least one parent is employed full-time 1.49 (-0.02; 3.00) 0.05 
Age at which child received primary diagnosis   
≥ 2 years of age 1.00 - 
< 2 years of age 0.89 (-0.64; 2.43) 0.25 
Child sex   
Male 1.00 - 
Female 1.04 (-0.51; 2.60) 0.19 
Presence of genetic syndrome   
Not diagnosed with syndrome 1.00 - 








3.8 Unmet needs  
Most caregivers were unable to reliably determine any specialist services that the child 
required but could not attend. To determine unmet therapy needs, therapy visits 
attended were subtracted from those recommended as the minimum standard of care 
for children receiving early intervention therapy in our service. Majority of the children 
required both speech and occupational therapy comprising maximum of 24 therapy 
visits. Both groups of children had similarly high proportions of unmet needs: 0.66 (SD 
0.21) among those with ASD vs 0.69 (SD 0.21) among those with GDD, p=0.33 (Table 
8).  
 
TABLE 8. Distribution of unmet therapy needs among all children and within 



















therapy2 visits (A) 
24 (2) 24 (3) 24 (2) - - 
Number of 
scheduled (attended 
+ missed) core 
therapy2 visits (B) 
8 (5) 7 (5) 8 (5) - - 
Number of visits2 
that were not 
offered (A-B) 








               Distributional values are mean (standard deviation); difference between means provided with 95% confidence intervals, CI          
               with p-value calculated using t-test  
               1 Following best practices guideline (set as bi-monthly per child for both groups) 
               2 “Core therapy” defined as occupational therapy, physiotherapy and speech/language therapy using standard       
               recommendations for primary diagnosis  












Contributing to unmet therapy needs were missed appointments. About half of the 
children, 119/240 (49.6%) reported to have missed at least 1 booked therapy session 
(Table 9). The leading reasons cited for missed appointments included lack of 
transportation means (9.5%), commitment with other duties (9.2%), and lack of social 
support (9.2%). 
TABLE 9. Reasons provided for missing therapy visits among all children and 














11(4.6%) 9(7.2%) 2 (1.7%) 
Commitment with 
other duties 
22 (9.2%) 9(7.2%) 13(11.2%) 
Lack of transport 
means 
23(9.5%) 12(9.7%) 11(9.4%) 
Lack of social support 
 
22(9.2%) 8(6.5%) 14(12.1%) 
Child was unwell 
 
10(4.2%) 5(4.0%) 5(4.3%) 
Bad weather 
 
5 (2.1%) 1(0.8%) 4(3.4%) 
Problems at the 
facility 
13(5.4%) 7(5.6%) 6(5.8%) 
Others 
 
13(5.4%) 7(5.6%) 6(5.8%) 
Total missed 
appointments 













CHAPTER 4 DISCUSSION AND CONCLUSIONS 
4.1 Discussion 
The aim of this study was to compare HSU patterns of children with ASD and GDD 
attending services at a tertiary facility. Overall, the mean frequency of health care visits 
in this cohort was 12.4 visits per child per annum. We observed a higher service use 
among children with GDD (13.3) compared to those with ASD (11.5). This primarily 
reflected higher frequency of specialist visits in children with GDD VS ASD (4.0 vs 
2.0), because of their higher comorbid diagnoses (41.0% vs 12.1%) and higher 
syndromic diagnoses (37.1% versus 9.5%). These findings differ from observations 
made in studies done in the USA  which have demonstrated higher annual outpatient 
visits among children with ASD compared to those typically developing (42, 44), as 
well as those with other NDD across various services (86, 96). This included physician 
visits, psychiatric visits, and core therapy visits. One possible explanation to this 
variance stems from the fact that children with GDD recorded more multisystemic 
medical conditions, and congenital/genetic conditions than those with ASD, which 
necessitated more specialist consultations. Secondly, chronic illnesses may have 
contributed to their developmental delays. However, though presence of >1 
documented comorbid condition was considered as a need variable, it was not a found 
to be a predictor of higher service when analysed overall, and specifically among 
children with either ASD or GDD.  This was contrary to findings of study by Zukerman 
and colleagues (2017) in the USA which reported higher service use among those with 
severer illness (58).  
Much lower frequency of comorbidities was reported in this cohort, and these 
comprised largely of medical conditions (27%) and congenital/ syndromic diagnoses 
(24%). Much fewer children had documented comorbid NDD, psychiatric or 
behavioural comorbidities. These findings again contradict various studies that have 
reported high comorbid conditions in children with ASD from low income countries. 
Springer and colleagues (2013) in SA reported a high prevalence of behavioural 
problems (89%) in children with ASD (40). Similarly, Mpaka and colleagues in the 
Congo also found high rates of comorbidities including epilepsy (72.5%) and ID 








Belhadj and colleagues (2006) examined Tunisian children with ASD and documented 
comorbid ID in over 60% of cases studied (76). Bakare and colleagues (2011) in 
Nigeria also documented associated comorbid ID, epilepsy and oculocutaneous 
albinism in children with ASD (164). Similarly, studies done in the USA, have reported 
high ADHD and GDD/ID in children with ASD, and high behavioural and psychiatric 
comorbidities (87-97%), which accounted for most of the specialist and ED visits (38, 
84). The low prevalence of mental health problems in our study may have arisen from 
various factors. Firstly, our study focused on preschool aged children, where these 
conditions are more easily manageable, compared to older children. Secondly, the 
clinical diagnosis in this study was done retrospectively from medical records. Under-
diagnosis by clinicians may have arisen due difficulties in identification of comorbid 
conditions in non- verbal children with ASD, because of the lack of appropriate 
diagnostic tools. Thirdly, reduced awareness and stigma around mental health 
diagnosis may have contributed to low concerns raised by caregivers, hence the 
diagnosis. This may also explain the lower specialist visits, that led to lower overall 
service use in the ASD group. There is need for clinicians to raise their index of 
suspicion of these non-physical comorbidities, and to develop local tools for screening 
of all children with ASD for comorbid  NDD and mental  before starting on treatments 
(80).  
Overall, other predictors of HSU in this cohort included being female, younger age, 
concurrent syndromic diagnosis, but these did not remain significant after controlling 
for primary diagnosis, hence were considered as confounders that were predictive of 
GDD diagnosis. In this cohort, 64% of caregivers were either married or cohabiting, 
and this was similar in both groups. The caregiver being married or having a partner 
was associated with higher service use in ASD households, suggesting better family 
stability was associated with improved service use. One third of families (33%) 
reported having no social supporter to accompany them to the health facility, and this 
was higher (40%) among households of children with GDD. However, the lack of a 
social supporter was not found to predict lower service use. Various studies have 
made empirical observations of high separation/ divorce rates among families of 








for the child. However, study by Freedman and colleagues (2011) done in the USA did 
not find this to be true (165). 
We observed lower specialist visits in those with ASD compared to GDD. This partly 
reflects the lower documented comorbid disorders in the ASD group but may also 
reflect unmet specialist visits in this group, arising from underdiagnosis of 
comorbidities. Similar findings were reported by Krauss and colleagues in the USA 
who observed that one third of children with ASD, compared to just one fifth of children 
with ID and one fifth of children with other special care needs reported experiencing 
problems accessing specialty medical care services (49). Improved identification of 
comorbid diagnoses may increase specialist referrals. 
Overall, the mean annual emergency visits were 1.0(1.0-2.0) visit per year, and this 
was similar in both groups. This ED visit rate is however much lower compared to 
studies in USA that have reported greater ED visits, especially among ASD children 
(26, 102). Deavenport and colleagues (2015) in their study assessing factors 
associated with ED utilization, reported that children with ASD had 0.26 times more 
annual ED visits compared to non-ASD children (102). However, the leading causes 
ED visits from this cohort were respiratory infections and unspecified fevers, which is 
like what they found. USA based studies have also reported 1.2 times higher rates of 
accidents or injuries among children with ASD compared to those with GDD presenting 
to ED (99, 100). On the contrary, accidents accounted for only 8.7% of all ED visits in 
our study. It may be that minor injuries were handled at home and did not reach the 
health facilities. Likewise, mental, and behavioural problems accounted for only 5.7% 
of ED visits in this cohort. This is contrary to observations made in the USA, which 
reported high psychiatric presentation among ED visits in children with ASD (26, 34). 
Possible explanations to this include issues such as cultural perspectives of mental 
illness, beliefs around effectiveness of interventions offered, and reduced awareness 
of possible existing interventions. Other potential barriers in LMIC households include 
the fact that health care systems place more focus on “life threatening” or serious 
medical illnesses due to financial constraints. 
The mean annual rate of therapy visits was 6.0 (2.0-10.0), and this again was similar 








and low visits imply reduced intensity of therapy for these children. Furthermore, we 
noted a large disparity in number of therapy services accessed per child, with up to 
15% of children not receiving any therapy in the preceding year, yet the highest 
attended had 18 sessions in the year. Higher annual outpatient rates have been 
observed in USA based studies, in children with ASD, with some exceeding 41 visits 
per child per annum (42), and therapy formed the largest proportion of these outpatient 
visits. This low therapy uptake can be attributed to low importance attributed to therapy 
by households, or to limited access to therapy services (54). The latter is further 
supported by the fact that 68% of children in this cohort reported unmet therapy needs 
in this cohort. There has been a growing demand for therapy services, especially in 
urban areas, that has overstretched available capacity. However, demand for service 
does not always translate to utilization. Research has shown that contextual factors 
such as organizational features or provider characteristics may contribute to limited 
utilization (53). Most children in this study accessed therapy at CDH. Inefficiency, due 
to limited number of trained personnel and other resources may discourage service 
use in these primary level centres. This is further supported by the low parent ratings 
of their previous experiences in respect to the physical environment, and facility 
management of disruptive behaviour at CHD. In addition, areas of service 
dissatisfaction as reported by parents included accessibility and convenience, and 
limited time spent with health providers. The World Health Organization (WHO) 
recommends provision of EIT in the child’s naturalistic environments, either through 
home-based care or at nearest community rehabilitation centres. This offers 3 
advantages, as it allows caregivers to work in familiar environments, reduces time and 
travel costs, and maintains the family unit. Community service should be accessible, 
affordable, acceptable, equitable, efficient, and sustainable. Therapy access could be 
improved by better systemic structuring, re-organization of therapy programs to reduce 
inconvenience to families, promotion of group therapy sessions to bridge the demand 
gaps and building of capacity.  
Because of lack of practise guidelines on intensity of interventions for the various NDD 
locally, most facilities strive to provide at least 1 session per discipline per month as 
the routine standard of care. Children therefore receive varying intensity of EIP 








therapy visits in children with ASD as in those with GDD. On the contrary, some studies 
have observed that children with ASD receive the lowest quality of care of all CWSN 
(166). Contributors have included sociodemographic characteristics of families (65, 
167), condition severity (166), and complexity of care needs (38, 166). ASD children 
that receive high quality care, both they and their families may have improved health 
outcomes and functional status (62). Lack of practice guidelines prevents facilities 
from optimizing individual therapy needs to meet the child’s needs, and parents from 
demanding better services for their children, during this narrow window of opportunity, 
when EIP makes the greatest impact on outcomes.  
Primary care is important for disease prevention, health promotion and monitoring of 
children health in general. The recommended frequency of primary care visits for 
children between 3-5 years is biannually, and annually thereafter. In addition to other 
scheduled childhood vaccinations, the World Health Organization (WHO) also 
recommends yearly flu vaccination for children with NDD. In this cohort, 73% were up 
to date on immunizations, but only 42.9% had attended at least 1 primary visit in the 
preceding year. It means that most children did not attend any primary care services 
after completing their primary immunizations. This therefore suggests suboptimal 
primary care for this group, despite their numerous health encounters. Similar 
observations were observed by Cummings and colleagues (2016) who observed that 
children with ASD were less likely to receive preventive services. On the contrary, 
other studies in developed countries observed either no difference (60), or slightly 
higher (63) attendance rates in primary care visits between ASD compared to non-
ASD children. The high pressure on caregivers to attend other services may make 
them forgo primary care visits. This could be minimised by integrating all services 
needed, to reduce inconvenience to caregivers. 
Health financing is an enabling factor, and low family income often poses a barrier to 
health service access globally (59, 86).  Though households with children with ASD 
had higher parent employment rates compared to those with GDD (42% vs 29%), 
overall, most (87%) households in this cohort had a net family income of <R8000 per 
month. Controlling for other confounders, households with children with ASD, who 








higher number of annual visits associated with caregiver tertiary education. On 
multivariable analysis, parental employment emerged as the strongest residual 
predictive factor for increased service use. Similar findings were reported by Irvin and 
colleagues (2012), who observed that higher SES was associated with receiving more 
services (105). Efforts to improve HSU in low resourced countries have focused on 
elimination of financial barriers to access, by making service free in children. However, 
medical expenses typically make up only a small portion of overall spending by 
families caring for children with special needs (168). Non-medical expenses covering 
transportation costs, modifications to houses, specialized childcare, and special food, 
clothing, and other items, can cause huge financial burdens on families. Spending on 
these out-of-pocket medical expenses may drive household to experience 
catastrophic economic burden and fall into poverty, denying then access. Removing 
financial hardships is particularly crucial for developing countries where out-of-pocket 
is the main payment strategy for health care. This could be mitigated by provision of 
the child support grants, and by designing programs that optimize care, but containing 
out-of-pocket costs.  
HSU is largely consumer oriented, and uptake is subject level of knowledge, 
experiences, and perceptions of illness. To achieve optimal utilization of services, we 
need to enlist cooperation of caregivers. Qualitative assessment on illness perceptions 
found similarities in both ASD and GDD groups. The lowest perspective ratings were 
observed in two dimensions; treatment control and understanding of illness. Overall, 
caregiver belief that therapy was able to control illness and that the caregiver had 
personal control over the illness (p<0.001), predicted higher HSU. Similar 
observations were reported in a study done in France which demonstrated correlation 
between parental beliefs around the cause of illness and service use (117). On the 
other hand, in study done in the USA, caregiver belief in environmental causes was 
associated with receiving >20hr per week of ASD- related therapy per week (118). 
Parents face difficulties understanding these conditions, and this makes them resort 
to CAM use. One third (27.9%) of families in this cohort reported CAM use. This was 
similar in both ASD and GDD groups. Similar observations were made in the USA by 
Chadeiz and colleagues (2018) who observed that believe in environmental 








CAM use (118). On the other hand, in study by Zukerman and colleagues (2017), high 
CAM use was reported in households with no knowledge of aetiology, and those with 
severer illness (94). We observed higher HSU among households of children with 
ASD, whose caregivers reported CAM use, likely reflecting need factors related to 
severity of the diagnosis. On the contrary, Levy and colleagues (2010), documented  
high CAM use in families that had delay in diagnosis, delay in onset of EIP, or when 
access to conventional care was limited (35). Akins and colleagues (2014), observed 
similar findings of high CAM use among those with the most intensive therapy and 
those with higher education (96). Therefore, clinicians need to openly discuss CAM 
use with clients to allow informed decision making. 
The level of family distress was found to be similar in both groups, however, in 
households with children with ASD, each 1unit increase in the ‘Brief IPQ score’ for 
personal control was associated with 1 more annual visit. This concurs with findings 
from study by Thomas and colleagues (2007) done in the USA, where parental mental 
health predicted increased ED use in families with ASD children (104). Similar findings 
were reported by studies done in Canada by Lunsky and colleagues (2012, 2017), 
they observed higher ED attendance by families of adolescents and adults with ASD 
experiencing distress (138, 139).  In this study, there was however low linkage to 
auxiliary services such as family counsellors, despite their role in supporting families 
in distress. Brief family distress measures can assist clinicians to determine those 
needing more interventions (157).  
The overall satisfaction level was 68.3%, with highest rating in communication and 
technical quality. However, clients expressed some dissatisfaction with the physical 
environment, which was largely related to disruptive behaviours arising from the 
overstimulating hospital environments in waiting area. Some caregivers also felt that 
instructions provided for home therapy were inadequate. USA based studies have 
reported significant dissatisfaction among households of children with ASD 
experiencing less collaboration, more disagreements and more dissatisfaction with 
services received (64, 65), reflecting poor partnerships with their service providers. 
Ratings of experiences were similar in both groups. In households with ASD, higher 








was quite favourable, but the few areas of dissatisfaction need to be improved. Clients’ 
experience and opinions are important in improving health care services, shaping 
health policies, and providing feedback on the quality, availability, and responsiveness 
of health care services. 
In our study, the mean overall hospitalization rate was 22.5% per annum, but we 
observed a higher hospitalization rate in those with GDD, compared to the ASD group 
(31% vs 14%). Much higher hospitalization rates were observed in our study compared 
to studies in high income countries. Birenbaum and colleagues (1990) in the USA 
reported 10% annual hospitalization rates in children with ASD compared to 3% 
among those typically developing (169). On the other hand, Arim and colleagues 
(2017) in Canada found that children with NDD had three times more hospitalizations 
than typically developing children (41). The higher hospitalizations rates in our study 
reflected the multimorbidity diagnoses in the GDD group, but could also be a reflection 
of the higher prevalence of community based infectious diseases.  
4.2 Conclusions 
Children with GDD had greater HSU compared to those with ASD, primarily due to 
their higher specialist visits, because of higher prevalence of syndromic and comorbid 
chronic conditions. Overall, a low intensity of core therapy was observed in both 
groups, with majority not meeting the stipulated routine standard of care, reflecting 
high proportion of unmet therapy needs. Missed appointments also contributed to this. 
Health satisfaction level was favourable in both ASD and GDD households, but 
dissatisfaction was mainly reported in the time spent with health providers and 
accessibility and convenience of services. Low level of satisfaction predicted lower 
service use in households with children with ASD. Children from lower socioeconomic 
backgrounds were associated with reduced health service use. Having either parent 
in employment was the largest predictors of high service use. One third of households 
were using CAM therapies. Among households with children with ASD, use of CAM 
therapy as was associated with higher service use, reflecting perceived severity, a 
need factor.  We observed similar rates of family distress in families with children with 
ASD and GDD, but high level of family distress predicted HSU among households with 








4.3 Recommendations  
All services were generally underutilized. To minimize serve access disparities, future 
programs need to bridge financial access barriers by adopting strategies that can 
reduce out-of-pocket costs, such as provision of accessible and efficient community-
based programs, and through improved caregiver education on effective interventions. 
There is need to develop local clinical practise guidelines that target to optimise 
intensity of core therapy, to enable service providers and caregivers to adequately 
plan for these services, and therefore improve compliance. There is need to improve 
the recognition of comorbid mental and medical diagnoses among  children with ASD, 
by raising the clinician’s index of suspicion and developing culturally sensitive 
diagnostic tools will allow early intervention and institution of coordinated 
multidisciplinary services required by these children. Facilities need to implement 
client-oriented care, that focus on improving client experiences and level of 
satisfaction, by optimizing provider-patient contact time, and minimizing 
inconveniences caused to caregivers. This can strengthen the parent-professional- 
partnerships, improve care collaboration, and encourage open dialogue on CAM 
therapies. Providers should strive to recognize the family distress level among children 
with NDD, and subsequently link them to existing support services, as this may reduce 
unnecessary health service use.  
  
4.4 Future research 
There are several knowledge gaps on HSU in children with NDD that remain 
unanswered. There is need for a large multicentre prospective study, that can 
comprehensively quantify all the health service needs, unmet needs, and health 
service usage among these children. There is also need for a comprehensive 
assessment of out of pocket costs in care access for children with NDD, which will 
guide service planning and budgeting. Our study did not evaluate the how caregiver 
level of knowledge and stigma impacts on HSU among these children. The tools used 
to assess qualitative measures including perceptions, level of satisfaction, and family 
distress level, have all been validated in high income countries. There is need to 
assess the reliability and validity of these questionnaires in assessment of these 








complete the 12-page questionnaire, and others perceived the questions on 
experiences and on the level of satisfaction overlap significantly. Their adaptation to 
the local settings may be useful for future studies. There is need to develop better 
screening tools to evaluate comorbid mental, behavioural, and cognitive problems 
among preschool children with NDD in low income countries.  
 
4.5 Limitations 
There were 3 areas of potential sources of selection bias; Firstly, the study was done 
at a tertiary centre and therefore may not be representative of those attending private 
facilities, or those not accessing any services. Secondly, children referred to tertiary 
services are likely to be those with more severer problems, and multisystemic 
comorbidities. Thirdly, caregivers of severely affected children with ASD, were less 
likely to be included, as they unlikely to consent to participation in a 30-minute 
interview due to their behavioural challenges. Recall bias was inevitable from need for 
caregivers to recount events in the previous year, as underreporting of medical events 
increases over time. Emotional status of respondents at time of study may influence 
encoding and recall of events. Attendance to CDH was dependant on the record on 
the appointment card and patient recall and may have missed some visits that may 
have not been documented on the card. In this retrospective cohort design, the 
establishment of the primary diagnosis, and comorbid diagnoses in the children relied 
largely on a previous assessment, as documented in their medical records, and 
corroborated by parent reports. The diagnoses were not further validated by re-
assessments of children in this cohort. This may explain the limited description of 
comorbid mental health and NDD problems commonly seen in ASD. On the other 
hand, the physical comorbidities were more likely to be captured among children with 
GDD. As such, segregation based on the mental comorbidities were too few to allow 
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QUESTIONNAIRE ON HEALTH SERVICE USE IN CHILDREN WITH 
ASD/GDD 
Date: _______________________________     
Telephone contact ____________________ 
 
1.0 SOCIODEMOGRAPHIC AND ECONOMIC CHARACTERISTICS 
Please respond the statements in the table below regarding your family by ticking where appropriate. 
 
Code 1 2 3 4 5 6 
Who is the primary 







Father  Other 
 
 
Primary caregiver’s age 
group (years) 
 
< 25 25 – 30 31 - 35 36 - 40 41- 45 >45 





Single Separated Divorced  
Nationality of caregiver South 
Africa 
Congo Botswana Malawi Zimbabwe other 
Ancestry of caregiver 
 
White   Black  Coloured/
mixed 
Indian other  
Language spoken at 
home 
English Afrikaans Xhosa Mixed Other  
Type of neighbourhood 
you reside at? 
Low 













   
How many children 
(<6yrs old), live in your 
household 
1 2 3 4 5 6 
Where does child 
spend most of their 
day? 







 Mean family income 
per month (Rands) 
<2000 2000-3999 4000 - 5999 6000 -7999 8000 - 9999 >10,000 














Is dad in employment 













Does you receive any 








Other   
Highest level of 
education attained by 
carer? 










How long does it take 
you to come to Red 
cross Hospital (hrs) 
1 2 3 4 5 6 
How much does it cost 
you to come to Red 
Cross Hosp and back 
home (Rands) 
 None  
 
< 50 50- 99 100 -149 150 -200 >200 
What means of 
transport do you use to 






Do you have a helper 
that can bring child to 








   
How do you pay for 
child’s healthcare? 




Family Other  
Did child spend the last 
















1.1 CHILD CHARACTERISTICS 
Please provide us information about the child in table below. 
 
Code 1 2 3 4 5 6 
Birth order  
 
1st born 2nd born 3rd born 4th born 5th born Other 
Child’s age (years) 
 
2 < 3 3 < 4 4 < 5 5 < 6 6 < 7  
Gender 
 
Male Female     


















   
Age at first diagnosis <1yr 
 
1≤ 2yr 2 ≤ 3yr 3 ≤ 4yr 4 ≤ 5yr >5 
Where was diagnosis 
was first made 
Red Cross 
Hosp 





Time taken from parent 
concern to diagnosis 
1 ≤ 2yr 2 ≤ 3yr 3 ≤ 4yr 4 ≤ 5yr 5 ≤ 6yr  
Does child have any 
chronic medical 
problems? 
None Asthma HIV Tubercul
osis 
Seizures Other  
 
 











Has child received all 
primary immunizations 
Up to date  Missed >1 
vaccine (s) 
None Unclear   






(< 10) with 
meaning 






2- 3 word 
phrases 












2.0 HEALTH SERVICE USAGE PATTERNS 
 
2.1 Did you attend any therapy for the condition last year?  
1. Yes [   ]     2. No [   ]    3.Cannot remember [  ] 
2.2 If yes, where does child attend these services?   
 RXH [   ]    2. Day hospital [   ]    3. Private [   ]   4. Other ]____________________________ 
(For questions 2.3 -2.8 please indicate your response in table below) 
2.3 Did you get any appointments for therapy or other support services in the last 1 month, 
and how many times did you attend in last 1 month and then in last 1year? 
2.4 Did you need a service but could not access it or missed the appointment in last 1 year?  
 
  Number of clinics 
attended 
Unmet service needs in past 1 
year 








 Core therapies      
1 Speech/language therapist      
2 Occupational therapist     
3 Physiotherapist     
 Sub- total core visits     
 Auxiliary services     
4 Audiology      
5 Social worker     
6 Family counsellor     
7 Pharmacy     
8 EEG     
 Sub- total ancillary visits     
 
2.5 Please indicate main reason(s) for missing any booked sessions in the last year. 
[speech therapy (SLT), occupational therapy (OT), physiotherapy (PT), audiology (AD), Social 
worker (SW), family counsellor (FC), pharmacy (PH)} 
 
 Reasons for missed sessions Core therapy 
sessions  
Ancillary services 
  SLT OT PT AD SW FC Ph 
  1 2 3 4 5 6 7 
1 None missed        
2 Forgot appointment date        
3 Appointment date not 
communicated on time. 
       
4 Was late for appointment        
5 Had to attend work or other duties        
6 Did not have transport/fare to go        
7 Did not have any social support        
8 Child was unwell        
9 Bad whether        
10 Travelled out of Cape Town        











EMERGENCY SERVICES (medical and mental health problems) 
 
2.6 Did this child experience any emergency medical problems/injuries or behavioural 
problems last 1 year? 
 1. No [   ]    2.  Yes [   ]     3. Cannot remember [   ] 
 
2.7  Please indicate in the table below the emergency problem(s) that brought child to 
hospital, number of visits and facility visited in last 1 year.  
 (ED RXH= Emergency dept RXH, Dev clinic RXH = Development clinic at RXH, CDH= Community 
day Hospital) 
 












CDH  Private 
facility 
Chemist 
   1 2 3 4 5 
Medical conditions         




1       
Seizures/epilepsy 2       
Sleeping problems 3       
Allergies 4       
Infection/fever 5       
Cough/flu/Pneumonia 6       
Trauma/Accidents       
(falls, bruises, cuts, burns) 
7       
To collect medications 8       
Total medical visits       
Mental health problems        
None 0       
Hyperactive, distracted, 
impulsive 
1       
Overly anxious 2       
Overly excited 3       
Mood swings 4       
Withdrawn, not talking or 
feeding 
5       
Aggression 6       
Irritability or agitation 7       
Very rigid behaviours 8       
Very restricted 
behaviours 
9       
Elopement/escape/ 
wandering off 
10       
Self-injurious behaviours 11       
Total behaviour visits        
Total emergencies 
 









2.8  Did child ever require emergency services, but you could not access on it time? 
 1. No [   ]   2. Yes [  ]   3. I don’t remember [   ] 
2.9  Please indicate what time of day you sought emergency services for the child and for 
what condition and whether the child required an overnight stay or admission? 
 
      Timing of emergency services        Hospital stay 
Working 










for >24 hrs 
       1      2      3        1        2 
Medical conditions       




1      
Seizures/fits 2      
Sleeping problems 3      
Allergies 4      
Child infections /fever 5      
Cough/flu/Pneumonia 6      
Trauma/Accidents 
(falls, bruises, cuts, 
burns) 
7      
To collect medications 
 
8      
Total medical visits 
 
      
Mental health 
problems 
9      
Total behaviour visits 
 



























MEDICAL SPECIALIST CLINICS 
 
 2.10 Please indicate in table below how many times you got specialists’ appointments,    
        and number of specialist clinics attended in last 1 year?  
 2.11 Did you need any specialist services, but did not receive it for whatever reason? 
 
  Specialist clinics         Unmet specialist needs 
 








None 0     
Development 1     
Neurology 2     
Psychiatry 3     
Genetics 4     
Ophthalmologist 5     
Gastroenterology 6     
Pulmonology 7     
Allergy 8     
Cardiology 9     
Ear-Nose-throat clinic 10     
Surgeons 11     
Others (Specify) 12     
Total visits      
 
     
 
  WELL BABY CLINICS  
 
 2.12 Did the child ever attend any well baby services?  
        Please indicate in table how many times you ever went to hospital for primary care   
        services listed in the table below. 
 
  Number of times 
Code None  
0 Growth monitoring/ 
development screening only 
 
1 Flu vaccine  
2 Other vaccinations   
3 Health advice/education  
4 Other concerns  


















3.0 DRUGS AND COMPLEMENTARY THERAPY USE 
 
3.1 Has child been on any medications used regularly in the past year?   
      Please indicate which ones you have used in the table below? 
 
 Psychotropics drugs Yes 
 




0 None  0 None  
1 Risperidone  1 Inhalers (MDIs)  
2 Methylphenidate  2 Skin topicals  
3 Valproate (Epilim)  3 Laxatives  
4 Phenobarbitone  4 Anti - tuberculosis  
5 Carbamazepine  5 Omeprazole  
6 Other antiepileptic drugs  6 Prednisolone  
7 Antidepressants  7 HIV meds  
8 Antipsychotics  8 Immune modifiers  
9 Melatonin  9 Hormones  





       
3.2 Did you use any supplements, diets, or therapies other than those prescribed in hospital 
in past year? Please indicate which ones and how often they were used in table below? 
 
 CAM use Code Yes  Occasional 
     (1) 
Often  





None 0     
Dairy restrictions 1     
Casein free diets 2     
No sugar diets 3     
Omega 3 supplements 4     
Magnesium 
supplements 
5     
Vitamin supplements 6     
Other diets (Specify) 
 
7     
Other 
therapies 
Spiritual healing 1     
Acupuncture 2     
Zomotherapy 3     
Yoga 4     
Traditional healers 5     
Hippotherapy 6     


















4.1 CAREGIVER PERSPECTIVES 
On a scale of 0 to 4, with 0 being the lowest score and 4 the highest, 
 please indicate what you feel about the child’s illness by ticking in the table below.  
 
 Brief illness perception questionnaire 0 1 2 3 4 
       
1 How much does the illness affect your life?      
2 How long do you think the illness will continue?      
3 How much control do you feel you have over the 
illness? 
     
4 How much do you think the treatments can help the 
child’s illness 
     
5 How severe are the symptoms in the child?      
6 How concerned are you about the illness?      
7 How well do you understand the illness?      
8 How much does the illness affect you emotionally? 
(Does it make you angry, scared, upset, anxious, 
depressed?) 
     
9 Please list in rank-order the 3 most important 
factors that you believe caused the illness 
     
 1.      
 2.      
 3.      
 
 
4.2 FAMILY STRESS LEVEL  
 
Caring for a child with special needs can be demanding and stressful on the family.  
Please rate where you and your family currently are in terms of coping by ticking in the appropriate 
box in table below? 
 
Code Family distress score 
 
Tick 
1 Everything is fine. Not in a crisis at all 
 
 
2 Everything is fine, but sometimes we have difficulties 
 
 
3 Things are sometimes stressful, but we can deal with problems if they arise  
4 Things are very stressful, but we are managing to deal with the problems 
when they arise 
 
5 Things are very stressful, but we are getting by with a lot of effort. 
 
 
6 We have to work extremely hard every moment of everyday to avoid 
having a crisis 
 
7 We won’t be able to handle things soon. If one more thing goes wrong, we 
will be in a crisis 
 
8 We are currently in a crisis, but we are dealing with it ourselves  
9 We are currently in a crisis, and have asked for help from crisis services  
10 We are currently in a crisis and it could not get any worse  









4.3 EXPERIENCES IN HEALTH SERVICES 
Please rate your experiences in various service areas at Red Cross hospital (RXH) or 
Community day hospitals (CDH) in the table below.  
(Use scale of 0 - 4, where 0 = Not satisfied, 1= somewhat dissatisfied, 2= somewhat satisfied, 3= 
satisfied, 4= very satisfied) 
 
   Therapy   services Support 
services, RXH 
Specialist 
clinics, RXH RXH CDH 
 Communication with 
nurses / provider 
    
1 Treat patients with 
courtesy and respect 
    
2 Listened carefully 
 
    
3 Explain things in an 
understandable way 
    
4 Understand child’s 
behaviour, are empathetic 
    
5 Are efficient 
 
    
 Communication with 
doctors 
    
6 Treat patients with 
courtesy and respect 
    
7 Listen carefully 
 
    
8 Explain things in an 
understandable way 
    
9 Understand child’s 
behaviour, are empathetic 
    
10 Are efficient  
 
   
 Physical environment     
11 Therapy room is kept clean 
and in order 
    
12 Surrounding area/toilet are 
clean 
    
 Management of disruptive 
behaviour 
    
13 Staff did everything they 
could to help 
    
14 Provided a safe 
environment for child 
    
 Medication/therapy 
communication 
    
15 Clearly explained each 
intervention given 
    
16 Explained possible drug 
side effects 
    
 Please rate the overall 
quality services  









4.4 LEVEL OF SATISFACTION  
 
Please read each of the statements carefully and tell us your feelings about the care you are receiving 
currently, whether good or bad. 
 
By rating on a scale of 0-4, how strongly do you agree or disagree with the following statements by marking 
in the table below? 




5. Strongly agree 
 
    1 2 3 
 
4  5  
1 Doctors are good about explaining reasons for medical 
tests 
     
2 Doctor’s office had everything I needed to provide 
diagnosis 
     
3 The medical care I have been receiving is just about perfect 
 
     
4 Sometimes doctors make me wonder if their diagnosis is 
correct 
     
5 I feel confident that I can get the medical care I need 
without being set back financially 
     
6 When I go for medical care, they are careful to check 
everything when treating or examining me 
     
7 I have to pay for more of my medical care than I can afford 
 
     
8 I have easy access to medical specialists I need 
 
     
9 Where I get care, people have to wait too long for 
emergency treatment  
     
10 Doctors act too business-like and impersonal to me 
 
     
11 Doctors treat me in a friendly and courteous manner 
 
     
12 Those who provide my medical care sometimes hurry too 
much when they treat me 
     
13 Doctors sometimes ignore what I tell them 
 
     
14 I have some doubts about the ability of the doctors to treat 
me 
     
15 Doctors usually spent plenty of time with me 
 
     
16 I find it hard to get appointment for medical care right 
away 
     
17 I am dissatisfied with some things about the care I receive 
 
     
18 Am able to get medical care whenever I need it 
 
     
   
Others 
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CONSENT FORM FOR HEALTH SERVICE UTILIZATION PROJECT 
 
PRINCIPLE INVESTIGATOR: Dr. Florence Oringe 
ADDRESS: School of Child and Adolescent Health, Red Cross Children’s Hospital, 
and the University of Cape Town 
INVESTIGATORS CONTACTS: 0769501139 
TITLE: Health service utilization patterns by pre-school children with autism spectrum 
disorder in South Africa, a comparison with global developmental delay 
 
Dear participant, 
Research has shown that children with developmental disorders have very complex 
health care needs and there are significant disparities in health services access in 
these children worldwide. We are undertaking a research study whose aim is to better 
understand how existing health services are utilized by children with autism or global 
developmental delays, in order to identify any gaps in care, to assess level of 
satisfaction of clients and to identify access challenges. The findings will inform 
improvement of service delivery for these children. We invite your participation in the 
study. Participation is voluntary and there are no consequences of declining to 
participate.  
 
Why have you been invited to participate? 
Your child is one of those accessing services at Red Cross Children’s Hospital for the 
developmental conditions under investigation. As one of our clients, your participation 
is highly appreciated.   
 
What are the procedures to be followed?   
The researcher will access the child’s medical records to establish the diagnosis. You 








to respond to questions regarding your household and child characteristics, your 
patterns of attendance to various departments for the child, your experiences and 
levels of family coping and any access challenges and then report on your level of 
satisfaction  with our services in the past one year. 
 
Who will have access to your child’s medical records?    
Only members of the research team will have access to the child’s records and 
hospital attendance data. All information will remain confidential and if the results of 
this study are published individual participants will not be identified. 
 
Are there any risks involved in your child taking part in this research? 
No. There is no harm that will be caused to the child or yourself. Some questions 
asked during the interview may be personal, regarding access challenges and stress 
levels at home. However, you are free not answer or to discontinue the interview at 
any time. 
 
Will the child benefit from taking part in this research? 
Participation in this study has no financial or personal benefits. However, the 
information obtained will be used to improve health service provision for these children 
in future. 
 
What protection is in place for the research participant opinions 
Your identity by name will not be used on the research questionnaires. Instead you 
will be identified by study numbers to maintain confidentiality. No one will be victimized 
for their opinion.  
 
Will this benefit children from our own community? 
Yes. Findings will inform service delivery for children with similar conditions seeking 
health services in public services in Western Cape province. 
 
How will my privacy and confidentiality be guaranteed? 
Interviews will be conducted in a private consultation room. Utmost confidentiality will 
always be maintained, and information shared will only be used for purposes of this 
study and for publication of the research findings. 
 
If you have any questions you may contact the principle investigator Dr. Oringe whose 
contacts are provided above or Prof. Kirsty, Head of Department of developmental 














I have understood the information above and the terms of my participation in this 
study: I have been given a chance to ask questions for clarification which has been 
answered satisfactorily. I voluntarily choose to participate in this study. I understand 
that the information I will provide will be treated with confidentiality and kept private. I 
understand I can refuse to proceed with the interview at any time without any 
consequences. 
 









I, the undersigned have explained to the respondent the procedures in the study, the 
benefits and the risks involved in participating in the study in a language she 
understands. 
 
Name of interviewer 
 






                                               
 



















Correlation of other factors with health care utilization (a) overall; (b) restricted 
to children with primary diagnosis of ASD; and (c) restricted to children with 
primary diagnosis of GDD: mean differences with 95%CI from linear regression 
 
 
(a) Full cohort         
(N=240) 
(b) Children with GDD 
(n=124) 
(c) Children with ASD 
(n=116) 
























Chronic comorbid diagnosis 
No other known 
chronic diagnosis 
1.00 - 1.00 - 1.00 - 












Speaks >20 words and 
phrases 
1.00 - 1.00 - 1.00 - 


































































































































































































































Abbreviations: GDD, global developmental disorder; ASD, autism spectrum disorder; CI, confidence interval, 
Beta-coefficients represent mean difference in health care visits: comparing each category to the reference, or 
difference per unit increase for continuous variables 
1 p-value for interaction effect of indicated variable (e.g. child sex) with binary indicator for primary diagnosis 
(GDD vs ASD) is p<0.05, indicating likely presence of effect measure modification, i.e. p<0.05 suggests that the 
relationship between indicated variable and overall health care visits varies within subgroups of primary 
diagnosis 
 
 
